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ABSTRACT 
BACKGROUND AND OBJECTIVE: 
Surgical Site infection is the most common nosocomial infection encountered 
in post operative surgical wards. The advent of prophylactic antibiotic in surgery has 
changed the face of surgical site infection and reduced its incidence dramatically. 
But the use of prophylactic antibiotic in elective surgical cases is still a subject of 
controversy to surgeons. 
The objective of the study is 
- to reduce the post-operative wound infection at or around the surgical sites, 
such surgical site infection will prolong the duration of hospitalization by one week 
and also costs for the patients. 
- to reduce the prevalence of  hospital acquired infection. 
- to reduce the incidence of resistance to antibiotics. 
-to reduce the overall cost effectiveness to the patients. 
-Patients comfort and tolerance. 
-Adverse effect of antibiotics are minimized. 
 
 
 
 
  
Methodology: 
The material for the comparative study of prophylactic antibiotics in Minor 
cases was collected from 100 cases admitted under two groups of 50 each Group A1 
was given prophylactic antibiotic prior to sincision and Group A2 was given routine 
conventional 5 day Post op antibiotics. Material for Major cases was collected from 
100 cases admitted under two groups of 50 each Group B1 who received 3 doses of 
antibiotics, first dose Prior to incision, second dose 8 hours later and third dose 8 
hours after the second dosage. Cases other than clean cases were excluded from the 
study group. Post op wound was inspected for signs of infection and graded 
according to Southampton scoring. 
Results: 
In Minor surgery, two out of 50 patients in group A1 who were given one dose 
of  antibiotic prior to incision were infected and 2 out of 50 patients in Group A2 
who received conventional Antibiotic coverage were infected. In Major surgeries, 
amongst Group B1 who were given three dose of antibiotic coverage three cases out 
of 50 were infected and in Group B2 who received conventional 5 day Antibiotic, 
two cases out of 50 patients were infected. 
 
 
 
 
  
Conclusion: 
Based on my study I would like to conclude that it is recommendable to use 
single dose antibiotic prophylaxis using appropriate antibiotics for all Minor 
surgeries and three dose of Antibiotics for Major surgeries, as per the study results 
there is no significant difference in incidence of SSI when compared to the traditional 
regimes with the added advantage of significant reduction in hospital stay, with its 
resultant savings in resources. In addition as the use of antibiotics is reduced it further 
results in increased cost effectiveness and reduces the incidence of complications due 
to antibiotic overuse. 
 
Key words: 
 Surgical site infection, prophylactic antibiotics nosocomial infections. 
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INTRODUCTION 
Surgical site infection (SSI) is one of the most frequent causes of post- 
operative morbidity. Surgical site infection is the most common nosocomial 
infection in our population accounting for 38% of all infections in surgical 
patients. Incisional infections are the most common accounting for 60% to 80% 
of all SSIs. 
Antimicrobial agents were considered as magic bullets and effective 
tools to combat infections in various therapeutic settings. However, the non-
judicious usage of these antibiotics has become a subject of controversy. 
Rational antibiotic use is promulgated with much vigor as the resultant effect of 
injudicious antibiotic usage had propelled the emergence of antibiotic 
resistance and spiraled the cost escalation in therapeutic care.1Antibiotic 
resistance has become a global menace, and WHO in 2012 had given a clear 
call to reduce the antibiotic use and prevent resistance to antibiotics .Antibiotic 
prophylaxis is a therapeutic method in which antimicrobial agents are used 
prophylactically to prevent the infectious complications in a therapeutic 
procedure. In conventional antibiotic use, antimicrobials are used for a 
predetermined period after therapeutic procedure to combat the infection .In 
this era of antibiotics, the cornerstones of infection control, such as meticulous 
surgical skill, respectful tissues handling, inbuilt environmental sanitation, 
adequate preoperative preparation, congenial theater environment, and 
adequate wound care, are given less priority .As per various studies cited and 
Cochrane data reviewed the conventional use of antibiotic for much longer 
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period are not justified. Most often in public hospitals where the environmental 
hygiene is not adequately maintained and over load of surgical patients with the 
fear of development of surgical site infections even for clean and clean -
contaminated surgeries antibiotics are given for 7-10 days. The traditional 
approach for this multi dose usage often leads to huge expenditure to the 
hospital and enhance emerging of resistance to the particular drug and the 
group to which it belong. 
Hence this study is intended to study the effect of single dose of 
antibiotic in minor surgeries and 3 dose antibiotic in major surgeries against the 
conventional 5 day antibiotic therapy. 
 
 
 
 
 
 
 
 
 
  
 
 
AIM OF THE STUDY 
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OBJECTIVES 
 To reduce the post-operative wound infection at or around the surgical sites, 
such surgical site infection will prolong the duration of hospitalization by one 
week and also costs for the patients. 
 To reduce the prevalence of hospital acquired infection. 
 To reduce the incidence of resistance to antibiotics. 
 To reduce the overall cost effectiveness to the patients. 
 Patients comfort and tolerance. 
 Adverse effect of antibiotics are minimized. 
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REVIEW OF LITERATURE 
HISTORY : 
The ancient Egyptians were the first civilization to have trained 
clinicians to treat physical aliments. Medical papyri, such as the Edwin Smith 
papyrus (circa 1600 BC) and the Ebers papyrus (circa 1534 BC), provided 
detailed information of management of disease, including wound management 
with the application of various potions and grease to assist healing. 
Hippocrates (Greek physician and surgeon, 460-377 BC), known as the 
father of medicine, used vinegar to irrigate open wounds and wrapped 
dressings around wounds to prevent further injury. His teachings remained 
unchallenged for centuries. Galen (Roman gladiatorial surgeon, 130-200 AD) 
was first to recognize that pus from wounds inflicted by the gladiators heralded 
healing (pus bonum et laudabile ["good and commendable pus"]). 
Unfortunately, this observation was misinterpreted, and the concept of pus 
preempting wound healing persevered well into the 18th century. The link 
between pus formation and healing was emphasized so strongly that foreign 
material was introduced into wounds to promote pus formation-suppuration. 
The concept of wound healing remained a mystery, as highlighted by the 
famous saying  by Ambroise Paré (French military surgeon, 1510-1590), "I 
dressed the wound. God healed it." 
The scale of wound infections was most evident in times of war. During 
the American Civil War, erysipelas (necrotizing infection of soft tissue) and 
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tetanus accounted for over 17,000 deaths, according to an anonymous source in 
1883. Because compound fractures at the time almost invariably were 
associated with infection, amputation was the only option, despite a 25-90% 
risk of amputation stump infection. 
The history of antisepsis dates back to 17th century as microbes are 
invisible to the unaided eyes. Definitive knowledge about them had to await the 
development of microscopes. The credit for having observed and described 
bacteria goes to Antony Van Leuwen Hock, a draper from Delft, Holland. In 
1663 he made accurate description of various types of bacteria which after 
some two centuries gained importance in field of medicine. The causative 
agents of various infectious diseases were being reported differently by 
different investigators, so it was necessary to introduce criteria for providing 
claims that a microorganism isolated from a disease was indeed causative. 
These criteria were estimated by Robert Koch in 1898 and are known as 
Koch’s Postulates. According to these, a microorganism can be accepted as 
causative agent of a disease only if the following conditions are satisfied : 
1. The bacteria should be constantly associated with the lesion of the disease. 
2. It should be possible to isolate the bacteria in pus culture from the lesion. 
3. Isolation of such pus culture into suitable laboratory animals should 
reproduce the lesion of the disease. 
4. It should be possible to isolate the bacteria by pus culture from the lesion 
produced in experimental animals. 
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Louie Pasture’s contribution to the field of asepsis was his techniques of 
sterilization, the development of a steam sterilizer, hot air oven and an 
autoclave (1880). Oliver Wendell Holmes in the USA (1843) and Ignaz 
Semmelweis in Vienna (1846) have independently concluded that puerperal 
sepsis was transmitted by the contaminated hands of the obstetrician. 
Semmelweis instructed them to wash their hands in chloride of lime before 
they attended women in labour. This resulted in reduction of maternal mortality 
from 11.4% in 1846 to 1.3% in 1848. 
Joseph Lister’s work in the field of antisepsis in surgery has totally 
revolutionized the concept of surgery. Lister’s technique of carbolic acid sprays 
and soaking of suture material as well as cleaning of surgeon’s hand in a very 
elaborate manner for protection against infection were not well accepted by 
anyone except the Germans who eventually through the work of Von 
Bergmann developed the technique of steam sterilization in 1886 under an 
elaborate antiseptic ritual in 1891.In the late 1860’s several surgeon became 
strong proponents of Listerism, but it was not until Halsted (1879) campaigned 
to aspect and meticulous techniques known to him, that his techniques became 
widely accepted in the US. They saw that if pathogen could be tentatively 
eliminated from the surgeon’s field of operation his chance of success would be 
far greater. 
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Definition and classification of Surgical Site Infection: 
Surgical site infections are infections of the tissues, organs and spaces 
exposed by surgeons during performance of an invasive procedure. SSI are 
classified into incisional and organ / space infection and the former is further 
sub classified into superficial and deep incisional categories. 
Fig:1 – classification of SSI 
 
Microbial density in tissue can be determined by the staining of a 
weighed and homogenized biopsy sample. However information based on this 
method is not available before operation. Therefore if antibiotic administration 
is to be started preoperatively, the decision must be on clinical basis. 
Fortunately there is a system of classifying surgical procedures based on the 
probability and the degree of microbial contamination. 
Superficial incisional wound infection must meet the following criteria. 
Infection occurs at an incision site within 30 days after operation and involves 
skin or subcutaneous tissue above the fascial layers and any of the following.
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1. There is purulent drainage from incision or drainage located above fascial 
layer. 
2. Organism is isolated from culture of fluid aseptically obtained from wound 
closed primarily. 
3. Wound is open deliberately by surgeon, unless wound is culture negative. 
Deep surgical wound infection must meet the following criteria. 
Infection occurs at operative site within 30 days after operation if no prosthesis 
was permanently placed or within layer if an implant was placed, and infection 
involves tissues or spaces at or beneath the fascial layer and any of the 
following 
1. Wound spontaneously dehisces or is opened deliberately by surgeon when 
patient has fever (>38o c) and / or localized pain or tenderness, unless 
wound is culture negative. 
2. An abscess or other evidence of infection directly under the incision is seen 
on direct examination, during operation or by histopathological 
examination. 
3. Surgeon declares infection. 
The surgical wounds are classified based on the presumed magnitude of 
the bacterial load at the time of surgery as clean, clean contaminated, 
contaminated and dirty. 
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CLASSIFICATION: 
Class I/Clean: Include those in which no infection is present; only skin 
microflora potentially contaminates the wound, and no hollow viscus that 
contains microbes is entered. 
An uninfected operative wound in which no inflammation is 
encountered and the respiratory, alimentary, genital, or uninfected urinary tract 
is not entered. In addition, clean wounds are primarily closed and, if necessary, 
drained with closed drainage. Class ID wounds are similar except that a 
prosthetic device ( eg. Mesh or valve) is inserted. 
 
Class II/Clean-Contaminated: Include those in which a hollow viscus 
with indigenous bacterial flora is opened under controlled circumstances 
without significant spillage of the contents. 
An operative wound in which the respiratory, alimentary, genital or 
urinary tracts are entered under controlled conditions and without unusual 
contamination. Specifically, operations involving the biliary tract, appendix, 
vagina, and oropharynx are included in this category, provided no evidence of 
infection or major break in technique is encountered. 
 
Class III/Contaminated: Include those open accidental wounds encountered 
early after injury, those with extensive introduction of bacteria into a normally 
sterile area of the body. 
Open, fresh, accidental wounds. In addition, operations with major 
breaks in sterile technique (e.g., open cardiac massage) or gross spillage from 
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the gastrointestinal tract, and incisions in which acute, nonpurulent 
inflammation is encountered are included in this category. 
Class IV/Dirty-Infected: include traumatic wounds in which a 
significant delay in treatment has occurred and in which necrotic tissue is 
present, those created in presence of overt infection. 
Old traumatic wounds with retained devitalized tissue and those that 
involve existing clinical infection or perforated viscera. This definition 
suggests that the organisms causing postoperative infection were present in the 
operative field before the operation. 
TYPES OF WOUND HEALING: 
Surgical wounds may heal by primary intention, secondary intention or 
by tertiary intention (delayed primary). 
Healing by Primary intention: 
Most heal by primary intention, where the wound edges are brought 
together (apposed) and then held in place by mechanical means (adhesive 
strips, staples or sutures), allowing the wound time to heal and develop enough 
strength to withstand stress without support. The goal of surgery is to achieve 
healing by such means with minimal oedema, no serous discharge or infection, 
without separation of the wound edges and with minimal scar formation. 
11 
 
Haemostasis and Inflammatory Phase : 
 
 
 
Fibroplastic Phase : 
 
Remodelling Phase : 
 
 Fig 2:Phases of Wound Healing 
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Healing by Secondary intention: 
Healing by secondary intention happens when the wound is left open, 
because of the presence of infection, excessive trauma or skin loss, and the 
wound edges come together naturally by means of granulation and 
contraction.21 
Healing by Tertiary intention: 
On occasions surgical incisions are allowed to heal by delayed primary 
intention where non-viable tissue is removed and the wound is initially left 
open. Wound edges are brought together at about 4-6 days, before granulation 
tissue is visible. This method is often used after traumatic injury or dirty 
surgery.22 
Healing by Primary intention: 
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Healing by Secondary intention: 
fig 3: Types of Wound Healing 
Factors Affecting Wound Healing: 
The factors that may adversely affect the wound healing can be 
conveniently considered in two categories: factors, which locally affect wound 
repair (local factor) and the systematic abnormalities which have remote effects 
on the wound (systemic factors). 
Local Factors: 
The local factors which have been implicated in the failure of wound 
healing are 
1. Surgical technique. 
2. Blood supply. 
3. Mechanical stress. 
4. Suture materials. 
5. Suture technique. 
6. Infection 
7. Radiation 
14 
 
 
Surgical Technique: 
The most important local factor in pathogenesis of wound complications 
is performance of the surgeon. Indeed, this is the single most important factor 
in the success or failure of wound healing. One might then expect that surgeons 
in training would experience a higher incidence of complications than qualified 
senior surgeons and there is some evidence to support the case.  
The essentials of good surgical technique include gentle handling of the 
tissues, securing meticulous hemostasis, the prevention of any dead space in 
the wound, and the avoidance of tissue necrosis resulting from excessive use of 
surgical diathermy or strangulation of the tissues by the ligatures. The presence 
of one or more of these variables constitutes a barrier to the processes of 
cellular repair and they are the factors leading to propagate wound infection. 
Ischemic tissue, a wound hematoma,or a collection of serum in the wound is 
excellent media for the subsequent growth of bacteria. 
The relative merits of surgical diathermy compared to suture ligation in 
wound hemostasis remain controversial but there is probably very little 
difference between the two methods as far as they affect the wound healing 
both may cause problems if they are used incorrectly. Diathermy should be 
used sparingly and precisely. Ligatures on blood vessels should not strangulate 
adjacent tissues. Fine suture materials can be used for most blood vessels and 
absorbable sutures can be used for vessels in the subcutaneous tissues. 
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Hematomas or collections of serum usually occur when ever dead space 
exists in the wound. Dead space is created in surgeries involving the reflection 
of skin or tissue flaps and in obese patients and it must be said that a potential 
dead space is virtually unavoidable in certain surgeries. However, dead space 
can be reduced or obliterated either by applying external mechanical pressure 
or by the use of wound drains. In obese patients, there is often a large potential 
dead space in the subcutaneous tissue and suture obliteration or drainage of this 
layer is advisable in these subjects. 
Other local factors affecting wound healing such as blood supply of the 
wound and the presence or absence of mechanical tension may also be results 
of surgical technique and these are considered below. 
Blood Supply: 
A good blood supply is a basic factor in the success of wound repair; it 
is essential for the supply of oxygen and other nutrients required in the cellular 
and biochemical processes of repair and it is necessary for the removal of 
wound metabolites. 
Disease may lead to impaired blood supply of the wound. This is most 
frequently encountered in the surgical treatment of atherosclerotic arterial 
insufficiency of the lower limb. Any factor causing mechanical tension in the 
wound will have adverse effects on the blood supply. Extrinsic forces cause 
wound tension by distracting the wound edges. In the simple example of a 
sutured skin wound, the elastic pull of the unwounded skin on either side of the 
incision exerts a lateral pull on the wound edges. In wounds of the hollow 
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viscera and the abdominal wall, wound tension is also derived from the 
pressure within the lumen of the viscus or hollow cavity; the tension occurring 
in the wound is directly related to this pressure and the radius of the lumen 
according to the law of Laplace. 
The simple suture of wound therefore will inevitably result in wound 
tension and adverse effects on blood flow. It is difficult to state in quantitative 
terms the point at which such tension becomes harmful; the avoidance of 
tension in wound closure is a matter of surgical experience or expertise rather 
than a measurable parameter. Intrinsic wound tension or the buildup of pressure 
within the volume of the wound contents following suture. Some degree of 
swelling of the wound is a normal feature of the early phase of repair. It results 
from the inflammatory response which is a feature of the first few days in all 
wounds and the surgeon should allow for such changes by ensuring that his 
sutures are not tied too tightly. More serious problems of intrinsic wound 
tension occur in the presence of wound infection, hematomas and collections of 
serum. These factors may cause an injurious rise in tissue pressure within the 
relatively inelastic confines of the wound. The presence of ischemic tissue in 
the wound initiates a vicious circle whereby the ischemic tissue results in tissue 
swelling and the tissue swelling lead to a further reduction in blood supply of 
the wound. 
Mechanical Stress: 
The extrinsic forces affecting wound tension may cause wound 
disruption or it may be a consequence of excessive movement of the wound 
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edges. In the former case, the tension at the suture or wound interface created 
by the extrinsic forces becomes so greater that the sutures simply cut out 
through the wound edges, less commonly the suture material may break or the 
knots may slip. 
General surgeons are familiar with the effects of mechanical stress on 
abdominal wound healing a sharp rise in intra abdominal pressure caused by 
coughing or gaseous distension of the intestine may result in the abdominal 
wound disruption.  
Suture Materials: 
The choice of suture material in primary wound closure may have a 
significant bearing on the success of the subsequent wound repair. There have 
been striking developments in the manufacture of sutures in recent years and 
there is now an extensive range of naturally occurring and synthetic sutures.  
It has been suggested that the ideal suture may be defined as follows: 
1. It should hold the tissues in apposition for as long as the natural 
forces are insufficient to resist separation or stretching of the wound edges. 
2. It should handle easily and knot securely. 
3. It should provoke minimal tissue reaction and it should be quickly 
absorbed so that the infection is not encouraged and it should not result in sinus 
formation. 
 
Suture Technique: 
There are general aspects of suture technique which need to be observed 
in the primary closure of all wounds and there are certain technical aspects 
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which are peculiar to particular tissues or wounds. The general aspects include 
the careful apposition of the wounds. The general aspects include the careful 
apposition of the wound edges, the avoidance of strangulation of the tissues, 
the selection of suture materials which are sufficiently strong to provide 
adequate mechanical support to the wound and secure knotting of the wound 
sutures. Sutures should be inserted some distance away from the wound edges. 
The edges of the wound are weakened by collagenolysis for several days 
following wound closure and suture may cut out if they are too close to the 
wound edges. Knot security is provided by the ‘surgeon’s knot’ or square knot 
and this should always be used in preference to a ‘granny knot’. Monofilament 
nylon and polypropylene have poor knotting characteristics and at least five 
‘throws’ should be used to prevent knot slipping when these suture materials 
are used. 
Radiation: 
Problems of wound healing resulting from ionizing irradiation chiefly 
occur in the management of skin wounds in previously irradiated tissues. These 
problems are frequently encountered in the surgical treatment of recurrent 
malignant disease of the chest wall or head and neck. 
Infection: 
Bacterial infection is the most common complication of wound healing 
and it encountered in every surgical specialty. Multiple factors are involved in 
the pathogenesis of wound infection and the effects of infection are divers. 
Classical wound infection occurring in wounds closed by primary suture may 
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simply be a source of significant morbidity but infection in vascular operations, 
plastic surgery and orthopaedic surgery may have disastrous consequences. 
SYSTEMIC FACTORS: 
Systemic factors which may affect wound healing are 
1. Age 
2. Malnutrition 
3. Vitamin deficiency 
4. Zinc deficiency 
 
5. Trauma, hypovolemia and hypoxia 
6. Anemia 
7. Uremia 
8. Malignant disease 
9. Jaundice 
10. Corticosteroid drugs 
11. Cytotoxic and antimetabolite drugs 
 
SURGICAL MICROBIOLOGY: 
Surgical infections are usually caused by bacteria, but fungal and viral 
infections can also occur especially as post operative infections in immune-
compromised hosts. 
Bacteria: 
Bacteria can be classified according to staining characteristic with Gram 
stain (positive or negative), shape (cocci, rods, spirals) and sensitivity to 
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Oxygen (aerobic, facultative, anaerobic) or according to the combination of 
these characters. 
Gram positive cocci: 
Staphylococci and some streptococci species are the Gram positive cocci 
of interest to surgeons because of their ability to cause primary surgical 
infections and post operative infections. Staphylococci may be coagulase 
positive or coagulase negative. 
Staphylococcus aureus is the most common pathogen isolated from 
wound infections. A major factor in its pathogenicity is coagulase productions, 
although the mechanism by which coagulase production increases virulence is 
not known. Most coagulase positive staphylococci should be resistant to 
penicillin and require treatment by a penicillinase resistant antibiotic. Extensive 
use of penicillinase resistant Beta lactam antibiotics during past 2 decades has 
encouraged emergence of Methicillin resistant staphylococcus aureus (MRSA). 
Coagulase negative staphylococci are the most common organisms recovered 
in nosocomial bacteremia and are frequently associated with clinically 
significant infections of intravascular devices. 
Surgically important members of the genus streptococci include 
S.pyogenes, pneumoniae and the viridians group which includes S.mulleri, 
S.salaivarium. Streptococci are classified according to Lancefield classification 
and ability to cause hemolysis on blood agar, alpha hemolysis a zone of green 
discoloration around colonies containing intact red blood cells, beta hemolysis, 
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complete clearing of the area around colonies and destructions of red blood 
cells; and gamma hemolysis. 
Group A streptococci can cause infections of almost any organ although 
skin, subcutaneous tissue and pharynx are the most frequently affected areas. 
Streptococci are important pathogens because of their ability to cause post 
operative infections including cellulitis, wound infection, endocarditis, urinary 
tract infection and bacteremia. Enterococci are commonly recovered as a part 
of the normal flora of the gastrointestinal tract and the vagina. Enterococcal 
bacteremia has a poor prognosis in combination with intra abdominal or pelvic 
infections and is found most often in patients who here been hospitalized for 
long time. 
Aerobic and facultative anaerobic gram negative bacilli: 
Numerous gram negative rods that can cause human disease have been 
identified, but only a few are of surgical importance. The genera Escherhia, 
Klebsiella, Proteus, Enterobacter frequently can be cultured from patients with 
intra abdominal and pelvic peritonitis and abscess, post operative wound 
infection, pneumonia and urinary tract infection. 
Pseudomonas aeurginosia is the species responsible for most surgical 
infections. They are frequently found in immunologically compromised 
patients, especially if they have been hospitalized for some time. Because of its 
resistance to single antibiotic therapy, Pseudomonas infections are frequently 
treated with a combination of two antibiotics. 
Anaerobic Bacteria: 
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Anaerobic bacteria require reduced oxygen for growth. Virtually all 
anaerobic infections arise endogenously. The cell wall of anaerobic bacteria is 
important in abscess formation. The genus Clostridium is most virulent of all 
anaerobes. C.Dfficile cause pseudomembranous colitis and occurs in patients 
on antimicrobial therapy. 
Fungi: 
Fungi are the most primitive eukaryote organism and are classified as 
protists. Because of their cell wall similarity to mammalian cells they are not 
sensitive to antibacterial agents, and many antifungal agents are toxic to human 
cells. 
In surgical patients opportunists cause most infections. Candida albicans 
and other candida species are by far the most common. They cause infection in 
patients treated with broad spectrum antibiotics and steroids. These infection 
can be treated by stopping antimicrobial, correcting host defences and therapy 
with amphotericin B or one of the azole antifungal agents. 
Viruses: 
Viruses are obligate intracellular parasites and are distinguished by their 
having either DNA or RNA. CMV causes most viral infections in organ 
transplant recipients. Hepatitis B virus, hepatitis C virus and human 
immunodeficiency virus (HIV) are of importance of surgeons because of the 
possibility that they can become infected from patient exposure and that 
patients can potentially be infected from physicians who harbor the viruses. 
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RISK FACTORS FOR DEVELOPMENT OF SURGICAL SITE 
INFECTIONS: 
Patient Factor: 
 Older age  
 Immunosuppression  
 Obesity 
 Diabetes Mellitus 
 Chronic inflammatory process 
  Malnutrition 
 Anemia 
 Radiation 
 Chronic skin disease  
 Recent operation 
Local Factor: 
 Poor skin preparation  
 Contamination of instruments  
 Inadequate antibiotic prophylaxis  
 Prolonged procedure 
 Local tissue necrosis 
  Hypoxia 
  Hypothermia 
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Microbial Factors: 
 Prolonged hospitalization  
 Toxin secretion 
  Resistance 
 
Methods used in Prevention of Surgical Site Infection: 
 
1.Endogenous infections - Reduce bacterial content of hollow 
viscera. 
 Prevent access of bacteria to wound 
 Mechanical cleansing of wound 
 Prophylactic Antibiotics 
2.Exogenous infection - Aseptic technique 
 Design of surgical wards 
 Isolation of Infected patients 
 Non- woven operating room clothing 
 Laminar flow operating room 
 Ventilation  
 Prophylactic systemic antibiotics. 
3.Host resistance - Meticulous surgical technique 
 Delayed primary suture of contaminated wounds 
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The measures which may lead to a reduced incidence of wound infection 
are summarized above and to a large extent they follow naturally from the 
identification of the factors which cause infection. 
Endogenous infection: 
Contamination of the surgical wound by the host’s own bacteria resulting 
in the endogenous infection and it is a problem which is chiefly encountered in 
the surgical operations on the hollow viscera. The prevention of wound 
infection is therefore concerned with the prevention of wound contamination or 
with the use of techniques which may prevent the infective sequel of wound 
contamination. 
Wound contamination may be limited either by achieving a temporary 
reduction in the bacterial content of the hollow viscera and skin or by using 
mechanical  methods  which  prevent  bacterial  access  to  the wound. Most of 
the evidence suggests that former method is more effective in practice. 
Antiseptic preparation of the skin is a necessary prelude to the surgical 
incision and it results in a temporary reduction in the numbers of viable 
organisms resident in the skin; effect of skin preparation is partly due to the 
mechanical washing and partly due to the antimicrobial properties of the 
antiseptic wash. Complete sterilization of the skin is impossible but a 
satisfactory reduction in the skin flora is achieved with a 0.5% solution of 
chlorhexidine in 70% alcohol or l% iodine in 70% alcohol. 
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The prevention of bacterial access to the wound by mechanical methods 
has proved to be reliable. In a controlled clinical trial, Raahave found that 
disposable plastic wound drapes reduced the extent of endogenous and 
exogenous wound contamination. Disposable adhesive plastic skin drapes are 
commonly used to prevent the endogenous contamination of wound by skin 
organisms. The infective sequel of wound contamination may be avoided either 
by mechanical cleansing of the wound or by the use of antimicrobial agents. 
Mechanical cleansing of the wound is achieved by irrigation usually with a 
normal saline solution. The actual technique of irrigation  may involve gravity 
flow, bulb syringe irrigation or a pressurized pulsating jet lavage. 
Antimicrobial agents may be used locally by topical application or 
systematically in the prevention of infection in contaminated or potentially 
contaminated wounds. Topical agents may be either antiseptic solutions or  
antibiotics. Antiseptic solutions have generally proved to be ineffective with 
possible exception of povidoneiodine. Systemic antibiotics are effective in the 
prevention of wound  infection  when  therapeutic  blood  levels  are  achieved  
during  the  surgical operation; treatment started as prophylactic measure after 
the operation is probably of little value. Systemic treatment may be used either 
on a short term or on a long term basis. There are two distinct disadvantages 
associated with the prophylactic use of antibiotics. First, it has been shown that 
increased use of antibiotics results in an increased incidence of antibiotic 
resistant organisms in the hospital environment and this is inevitable 
consequence of long term antibiotic therapy. However, there is no evidence 
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that short term therapy is associated with this risk. The second problem is the 
hazard of pseudomembranous colitis. The factors involved in the pathogenesis 
of this disease are obscure but it is associated with broad spectrum antibiotics  
lincomycin and clindamycin have been associated with a particularly high 
incidence of this disease but no broad spectrum antibiotic regimen may be 
exempted from this complication. Recent research has suggested that 
pseudomembranous colitis results from the suppression of the normal bowel 
flora and overgrowth of toxigenic strain of clostridium difficle. 
Exogenous infection: 
Cross infection may be avoided by attention to various aspects of 
operating room and sterilized surgical materials, disinfection of skin and use of 
no-touch techniques in the dressing of surgical wounds all of which are 
designed to prevent the transfer of bacteria to the surgical wound. The available 
evidence suggests that such measures are relatively effective in prevention of 
wound infection and air borne bacterial contamination of the surgical wound 
appears to be more important causes of wound infection. 
It has been shown that traditional open ‘nightingale’ wards are 
associated with the higher incidence of wound sepsis compared with wards 
based on race-track principle. In the latter type of ward, clean and dirty areas 
are physically separated, air currents are controlled by positive pressure 
ventilation and patients are segregated in single rooms or in small units. 
Patients who have clinical infections caused by the pathogenic bacteria 
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such as staphylococcus aureus, Shigella or Salmonella must be isolated and 
barrier nursed. Ideally the general hospital should include an infectious disease 
unit in which such cases can be nursed. 
Cross infection or endogenous contamination of the surgical wounds 
may both occur postoperatively in the surgical ward. The wound is vulnerable 
to contamination through the suture line for 4-5 days and it should be protected 
during this period. Exceptions to this rule are wounds of the face or neck and 
perineal wounds. Wounds of the face or neck have an exceedingly rich blood 
supply. They heal rapidly and septic complications are rare. The anatomy of the 
perineum makes perineal wounds dressing a difficulty and rather pointless 
exercise but septic complications in wounds closed by primary suture are 
surprisingly uncommon. There is now an enormous range of wound dressings 
but the choice really depends on the type of wound and its location. Dressings 
should be dry and occlusive : ideally they should also be non adherent so that 
fibrin coagulum of the wound suture line is undisturbed if early removal of the 
dressing is necessary. However, wound dressings should not be disturbed until 
sutures are removed unless there is a valid reason for an earlier inspection. 
In the operating room, cross infection is chiefly determined by the 
shedding or air borne dispersal of the bacteria by the operating room personnel. 
The staff in the operating room should be limited to an optimal number and 
unnecessary movement or talking should be discouraged. The use of nonporous 
or non-woven fabric clothing and operating gowns results in reduced bacterial 
dispersal compared with the woven cotton materials. 
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Steri-Drape Absorbent Prevention Fabric creates a barrier to inhibit fluid 
strike-through, reducing the need for multiple drapes and decreases chances of 
exogenous infection. Less draping means less time in application and removal. 
Fewer drapes to dispose off, therefore saving time and money. 
The standard ventilation system in the operating room is a plenum 
system providing 15-20 air changes per hours. The air is partially filtered, 
humidified, heated or cooled and it is pumped into the operating room. If the 
air flow is turbulent; air currents do not provide special protection of the 
surgical wounds and bacterial particles are slowly and inefficiently removed 
from the operating room. Recent developments in the techniques of operating 
room ventilation involve the use of highly filtered air in special operating 
enclosure or wound isolators or laminar flow ventilation systems. In the 
Charnley enclosure, the surgical team operates in a clean room within the 
operating theater. The room is ventilated with highly filtered air and bacterial 
emission by the operating team is reduced, by the use of special protective 
clothing and breath exhaust systems. The principle of laminar air flow is to 
eliminate turbulent recirculation of air at the operating site or wound and this 
may be achieved by vertical or horizontal air streams with a rate of air change 
of 600-700 times per hours. Vertical and horizontal laminar flow systems are 
probably quite similar in efficiency but horizontal systems have advantages in 
the cost and ease of operation. Ventilated wound isolators are even more 
economical but access to the patient is restricted by these devices and they 
are suitable only for a limited number of  operating techniques and exposures. 
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The possibility that intraoperative contamination of the wound may be 
an unimportant factor in the pathogenesis of wound infection may seem 
difficult to accept but cross infection is chiefly encountered in clean surgery 
and existing rates of wound sepsis in the surgery are very low; they are 
certainly much lower than the incidence of air borne contamination in clean 
wounds. The incidence of wound sepsis may be no more than l-2% in clean 
operations and surgical technique host resistance factors may play a much 
greater part in the pathogenesis of wound sepsis by comparison with cases of 
endogenous wound infection. 
Host Resistance: 
Local factors affecting host resistance are mainly related to surgical 
technique; infection is likely to occur in the presence of dead or devitalized 
tissue, foreign materials, wound hematomas or dead space. 
Grossly ischemic or devitalized tissue is most frequently encountered in 
traumatic wounds or in the amputation of limbs for peripheral arterial 
insufficiency.  In such cases, surgeon must be certain that all the dead tissues 
are excised and the blood supply of the final wound is adequate. Wound 
hematomas or collections of serum in the wound usually result from presence 
of dead space, and later may be consequence of unnecessary dissection or 
reflection of flaps comprising the skin and the subcutaneous tissue. In the 
presence of dead space, a closed system of suction drain is used to empty the 
space of blood or serum. The drains should be inserted through separate 
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puncture incisions rather than through the wound itself. Dead space also occurs 
in the subcutaneous wounds of very obese patients and closed suction 
drainage of such wounds may also be desirable. However, this may be 
unnecessary if the tissues are carefully approximated with fine sutures of 
absorbable suture material or monofilament polypropylene. 
All sutures, prosthetic implants and wound drains behave as foreign 
bodies and they propagate wound infection. In most cases, the use of foreign 
materials is unavoidable, but the surgeon may be responsible for some cases of 
wound infection by the injudicious use of wound drains or certain types of 
suture material. There is a temptation for to surgeon to use braided materials 
because they are easier to handle than monofilament sutures, but braided 
materials have a greater tendency to propagate wound infection and 
monofilament sutures should be used in contaminated wounds45; monofilament 
nylon, steel, or polypropylene cause little tissue reaction and persistent sepsis 
or wound sinuses are rarely encountered with such sutures. The use of wound 
drains should have a rational base. It is acceptable practice to use drains to 
remove collections of blood or serum, but they are also used by some surgeons 
to prevent wound infection in contaminated operations. Whenever wound 
drainage is employed, the drains should be closed and they should emerge 
through incision separate from surgical wound. 
Clinical Features and Treatment of Surgical Site Infection: 
The clinical signs and symptoms of wound infection are varied and they 
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depend on several factors including the location or distance of the infected 
focus from the skin surface, the nature of infecting organisms and host 
resistance. The classical signs of infection i.e. heat, redness, swelling, pain and 
loss of function may or may  not be present. In most of the cases the diagnoses 
is finally with the discharge of pus from the wound either spontaneously or by 
deliberate opening by surgeon46. 
The peak incidence of onset of symptoms and signs of wound infection 
occur 3-10 days after surgery. 
Mild, moderate or severe fever is usually present but significant toxemia 
is unusual. In superficial wound infection limited to the skin and subcutaneous 
tissue, signs of infections are usually immediately apparent on examination of 
the wound. The surrounding skin is edematous and red. The wound is 
exquisitely tender on palpation and a purulent discharge may be present. The 
diagnosis is confirmed by gently separating the edges of the skin incision with 
a sinus forceps and pus is released from the subcutaneous tissue. In deep 
wound infection arising beneath the fascial layers, clinical signs of infection 
may be absent on examination of wound apart perhaps from some tenderness 
on palpation, presence of unexplained fever in such cases often prompts a 
search elsewhere for other possible foci of infection47. 
The nature of the pus discharge may provide a clue to the species of 
infecting organisms. Staphylococcal infection traditionally produces creamy 
yellow pus, pseudomonas pus has a characteristic odour and it may cause green 
or blue staining of the wound dressing. Proteus infections have a fishy odour 
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and infections following intestinal surgeries which are frequently mixed 
infections involving bacteroid species and aerobic coliforms produce pus which 
looks and smells like liquid faeces48. 
In majority of cases, the treatment of wound infection is a relatively 
simple matter and consists of providing adequate drainage of the infected 
wound. When pus is already discharging though the skin, the drainage tracts 
are gently stretched with a sinus forceps. The sinus forceps is pointed in 
various directions deep to the skin so that all foci of infection are drained. It is 
rarely necessary to open the wound widely  or to conduct a formal wound 
exploration under anaesthesia, although this is occasionally necessary in cases 
of deep wound sepsis located beneath the facial layers. 
Aggressive soft tissue infections are rare, difficult to diagnose, and 
require immediate surgical intervention plus administration of antimicrobial 
agents. Failure  to do so results in an extremely high mortality rate 80 to 100%, 
even with rapid recognition and intervention, current mortality rates remain 
approximately 30 to 50%. 
Role of Laboratory in Infection Diagnosis: 
A variety of laboratory tests may be helpful in determining the timing of 
therapeutic intervention in patients with proven or suspected infection. The 
basic procedures usually include a naked eye examination of the specimen, 
microscopic examination of Gram stain, and culture on aerobic and anaerobic 
blood agar plates, on MacConkey’s agar and in cooked meat broth. 
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Generally surgical infections are characterized by leukocytosis. Affected 
patients may have some degree of coagulopathy, glucose intolerance in septic 
patients, and may be seen with hypoglycemia. Ascending colangitis in infected 
patients with hyperbilirubinemia should be considered. From the point of view 
of surgical intervention, laboratory helps in defining laws of infection in 
isolating a specific organism or a group of organism and providing data that 
supports the worthiness of antimicrobial treatment in terms of insuring both the 
killing of organism and minimum toxicity from the dry closure. Gram stain is a 
simple procedure which pathogenic agents can be predicted and can guide as 
for empirical therapy. 
Wound swab from the local site of suspected infection should be 
cultured and blood cultures should also be sent along. The cases in which 
prophylactic antibiotic is administered, timely estimation of serum level should 
be done. The specimen should be inoculated on to two plates of blood agar, one 
for incubation in 370C aerobically, preferably in air plus 5-l0%, Co2, the other 
for incubation anaerobically in nitrogen / hydrogen pulse 5-10% Co2. The agar 
plate also has antibiotic walls to identify sensitivity. The culture plates are 
examined after overnight incubations at 37o C for 18-24 hours. If no growth, 
plate should be reincubated for another 24 hours50. Most surgical infectious can 
be managed well by using standard disc diffusion antibiotic susceptibility data 
and providing dosage of standard amount of antibiotics as required. Recent 
investigations such as accessing blood, CSF and urine by countercurrent 
immunoelectrophoresis or using latex agglutinations test for the presence of 
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antigens of pathogens such as streptococcus pneumoniae, hemophilus influenza 
or niesseria meningitides. Other techniques such as gas liquid chromatography 
are used to  identify footprints that are short chain fatty acids of anaerobes. 
The Pathogenic Bacteria Responsible for Surgical Infection: 
Surgical infections are usually caused by bacteria but fungal and mixed 
infections can also occur especially as postoperative infection in 
immunocompromised hosts. Most bacterial infections are due to organisms that 
are part of the patient's endogenous flora bacteria that are normal residents of 
skin or gastrointestinal tract. The various selected features of bacteria in 
surgical infection is as shown in the table below: 
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Table 1 : Organisms causing surgical site infection 
 
Organism 
Frequency 
of 
organism 
seen in 
Surgical 
Infection 
Likelihood of 
Single- 
Pathogen 
Surgical 
Infection 
 
 
Type of Surgical Infection 
 
AEROBIC 
BACTERIA 
Gram-positive Cocci 
Staphylococcus 
aureus 
 
 
High 
 
 
High 
Skin and wound abscess, infected 
I.V. catheter site, bacteremia, 
endocarditis, infected prosthetic 
device, pneumonia, 
postneurosurgery,meningitis, 
osteomyelitis, infected joint 
 
Staphylococcus 
epidermis 
 
 
Moderate 
 
 
Low 
Usually mixed infection but can 
cause bacteremia, 
ventriculoperitoneal shunt infection, 
endocarditis, skin infection. 
Streptococcus 
Pneumonia 
Moderate High 
Pneumonia, bacteremia, infected 
joint. 
 
Enterococci 
 
High 
 
Low 
Usually mixed infection - wound and 
intraabdominal abscess, 
endocarditis,urinary tract infection 
(UTI). 
Other Streptococcus 
Species 
Moderate Low 
Usually mixed infection- skin and 
wound infection, intraabdominal 
abscess. 
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Gram – negative 
Cocci Neisseria 
gonorrhoeae 
 
Low 
 
Moderate 
Tubo-ovarian abscess mixed 
infection with anaerobes, enteric 
bacilli and Chlamydia is 
Common 
Neisseria 
meningitides 
Low High 
Bacteremia, pneumonia (especially 
groupY ) 
Branhamella catarrhis Low Moderate 
Pneumonia (usually community 
acquired) 
Gram-positive bacilli 
Bacillus species 
(especially cereus) 
 
Low 
 
High 
Usually contaminant;may cause 
bacteremia, endophthalmitis 
JK-Diphtheroids Low High Bacteremia 
Gram-negative 
bacilli,Escherichia 
coli 
 
High 
 
Moderate 
Bacteremia, UTI, pneumonia; often 
in mixed infection wound, 
intraabdominal 
and pelvic abscess 
Other 
Enterobacteriaceae 
Klebsiella 
Enterobacter, 
 
High 
 
Low 
Mixed infection such as wound,intra- 
abdominal and pelvic abscess; 
occasional bacteremia. UTI and 
pneumonia 
Serratia and 
Providencia 
Moderate Moderate 
Occasional bacteremia, pneumonla, 
UTI 
Non-
Enterobacteriaceae 
Pseudomonas 
Aeruginosa 
 
Moderate 
 
High 
Bacteremia, pneumonia, wound 
infection (especially burn) 
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Gram-negative 
coccobacilli 
Haemophilis 
influenza 
 
Low 
 
High 
 
Pneumonia, sinusitis 
 
Acinobacter 
 
Low 
 
Moderate 
Often mixed infection; may cause 
UTI, pneumonia, intraabdominal and 
wound infection, bacteremia. 
ANAEROBIC 
BACTERIA 
Gram-positive Cocci 
Peptococcus, 
Peptostreptococcus, 
anaerobic 
streptococci 
 
Moderate 
 
 
Low 
 
Mixed infection, genitourinary 
infections, fasciitis 
Gram - Positive 
bacilli 
High 
Moderate to 
Low 
Usually mixed infection (wound, 
intraabdominal) gas gangrene, 
occasional devastating sepsis in 
genitourinary 
Infection 
Clostridium tetani Low High Causes tetanus 
Clostridium difficile Low High 
Causes antibiotic associated 
enterocolitis 
Clostridium 
botulinum 
Low High Causes wound botulism 
Gram-negative bacilli 
Bacteroides fragilis 
High Moderate Usually mixed infection 
Other Bacteroides 
Species 
High Low Mixed infection 
Fusobacteria Moderate Low Mixed infection 
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ANTIBIOTICS: 
Role of Antibiotics in Infection Management: 
The use of antimicrobials or antibiotics in surgical infections has come in a 
long way in prophylactic therapeutic management. The role of antimicrobial 
therapy is to prevent or treat infections by reducing or eliminating pathogenic 
organism until the host’s own defenses can get rid of the last pathogen. The 
basic consideration in choosing antimicrobial is efficacy, toxicity and cost 
effectiveness. Effective antimicrobial agent must be active against the 
pathogens causing the infections and must be able to reach the site of infections 
in adequate concentration and in particular time. 
All antibiotics have potential toxicity. Toxic effects may be idiosyncratic 
such as allergy or the rare instance of bone marrow aplasia caused by 
chloramphenicol or result in damage to tissue and organs as renal toxicity or 
ototoxicity seen with aminoglycosides and amphotericin B. Antimicrobial 
agents also exert selective pressure on the microbial ecology of hospital that 
leads to resistant microbes lost in the final consideration in the selection of 
antimicrobials. Determining antimicrobial costs include more than just the cost 
of the drug, the drug administration charges, nursing time, intravenous fluids 
and lines and monitoring costs must also be added to drug costs. 
Distribution of Antimicrobial Agents: 
Successful treatment of localized infections with systemic antimicrobial 
agents requires that an adequate concentration of antibiotics be delivered to the 
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site of infection ideally the tissue concentration of antibiotics should exceed the 
minimum inhibitory concentration. Tissue penetration depends on protein  
binding  of antibiotics. Only the unbound form of antibiotic will pass through 
capillary wall or act to inhibit the bacterial growth. Lipid solubility is also an 
important factor in tissue penetration. 
Blood: 
Rapidity of excretion and protein binding are two main determinants of 
blood concentrations of antimicrobial agents. Those that are highly protein 
bound are not excreted rapidly as those with a low binding affinity and thus 
have longer half lives. Efficacy of pencillins, Cephalosporins and other 
antibiotics that affect bacterial cell wall synthesis depend on the time during 
which serum levels are above the minimum inhibitory concentration rather than 
a peak serum concentration. 
Urine: 
Most commonly used antibiotics are excreted principally in the urine 
and achieves high urinary concentrations upto 50-200 times their serum 
concentrations. Notable exceptions are erythromycin and chloramphenicol. 
Since concentrating ability is severely compromised in patients with renal 
disease infectious of urinary tract are more difficult to treat in these patients. 
Bile: 
Beside urine, only bile has concentrations of antibiotics higher than 
found in serum. The biliary concentration of the penicillins especially 
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nafacillin, piperacillin and azlocillin, cephalosporins, especially cefazolin, 
cefamandole, cefamide, cefoperazone and cefadroxil frequently are several 
times that of serum. 
Intestinal fluids and Tissues: 
High prolonged serum concentration and low protein binding favor 
diffusion of antibiotics from serum into extra vascular tissue. Absolute tissue 
level may not accurately reflect the therapeutic potential because tissue may 
bind with antibiotic and thus be unavailable for binding to bacteria. 
Principles of Antibiotic Therapy: 
1. The organism should be sensitive to antibiotic chosen. 
2. Antibiotics should be in dose that ensures adequate peak concentration and 
tissue penetration. 
3. The Antibiotics should come in contact with the organism. 
4. Frequency of administrative is based on the half life and the route of 
eliminations of the antibiotics 
5. Choose a bactericidal antibiotic when appropriate. 
6. Use synergistic therapy when appropriate 
7. Avoid antagonistic combination of antibiotics 
8. Choose the most appropriate and narrow spectrum antibiotic 
9. Adverse effects should be evaluated and risk benefit balanced. 
10. Ensure proper duration of therapy to ensure eradication of pathogenic 
organism. 
In general if a single effective, nontoxic drug is used to prevent infection by a 
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specific microorganism or to eradicate an early infection, then 
chemoprophylaxis frequently is successful. 
Prophylactic Antibiotics: 
Ever since antibiotics became available they have been used to prevent 
infection in surgical practice. It has greatly evolved and grained much attention 
in the last 25 years. The objective of most antibiotic prophylaxis is to achieve a 
high tissue level of an appropriate choice of antibiotic and they have defined 
more clearly the value of techniques in reducing post operative wound 
infection. 
Selection and Administration of Prophylactic Antibiotic: 
An appropriate prophylactic antibiotic should be 
1. Effective against microorganisms anticipated to cause infection. 
2. Achieve adequate local tissue levels. 
3. Cause minimal side effects 
4. Be relatively inexpensive. 
The microbial content of the wound and the hospital environment may 
influence the choice of antibiotic but coverage should primarily target those 
organisms known to cause post operative infection. In general, a first 
generation or third generation cephalosporin fulfills these criteria and is 
regarded as sufficient prophylaxis for the majority of clean and clean 
contaminated surgeries. 
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Timing of Prophylactic Antibiotic Agents: 
It has been observed in laboratory that the effectiveness of antimicrobial 
agents in preventing infection diminishes as the time between contamination 
and the initial administration of the antimicrobial agent is lengthened. Timing 
of administration is critical. The drug should be administered within 30 minutes 
and certainly within 2 hours of the time of incisions. The first dose should 
always be given before the skin incision is performed. For longer procedures, 
re-administration of drug is indicated at internals of one or two times the half 
life of the drug. This ensures adequate tissue levels throughout the duration of 
the procedure. For clean procedures, only single dose with long half life in high 
dose is preferred. The duration of administration is extended only in special 
circumstances such as gross contamination secondary to ruptured viscus or 
trauma. 
Prophylactic Agents: 
The ideal prophylactic antibiotic needs to achieve a balance between 
safety and efficacy. Some commonly used agents are Beta - Lactam 
Antibiotics. The most common and largest class of antibiotics in current usage 
the term is derived from the presence of a unique four member beta-lactam ring 
in all agents in this class. These include penicillin, cephalosporins, the 
monobactams and the thiocyanins. 
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Penicillins: 
These are the oldest group of beta-lactams. It was first extracted from 
the penicillium notatum. With molecular manipulation on the original nucleus 
using modern biochemical techniques a large number of enhancements and 
alterations to bacterial sensitivity have been achieved. 
Cephalosporins: 
These are the largest group of beta-lactams in common usage the natural 
compound is procedure by the fungus cephalosporium. Cephalosporins have 
developed into series of generation with each generation representing a 
broadening of the antibiotic spectrum and activity. The agent within a given 
generation possesses similar antibacterial characteristics. 
First generation cephalosporins include cephalothin, cefazolin and 
cephalexin. These are most active against gram positive organisms like 
staphylococcus and streptococcus and are generally ineffective against 
anaerobes and many gram negative organisms. 
Second generation cephalosporins include cefoxitin, ceforoxime, cefatetan 
and cefaclor. These possess an increased activity over gram negative 
organisms, although their activity against gram positive organisms is less than 
the first generation, they are also effective against anaerobes. 
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Third generation cephalosporins have been most heavily developed in 
recent years. These include cefotaxime, ceftizoxime, ceftriaxone etc., These are 
beta lactamase resistant, thus have enhanced activity against aerobic gram 
negative bacteria they possess little activity over anaerobes. 
Fourth generation cephalosporins include cefipime and cefpirome which 
have broader activity and are effective against gram positive as well as gram 
negative organisms. 
Vancomycin : 
 Glycopeptide is most active against Gram-positive bacteria and has 
proved most effect against MRSA. It is effective against C.difficile and given 
orally  in cases of pseudomembranous colitis. 
Carbapenems : 
 Meropenem, ertapenem and imepenem are members of this group. They 
are stable to beta lactamases and have useful broad spectrum anaerobic as well 
as Gram positive activity. 
Imidazoles : 
 Metronidazole is most widely used member and is active against all 
anaerobic bacteria. Infection with anaerobic cocci and strains of Bacteroids and 
Clostridia can be treated or prevented by its use. 
Other agents that are used are 
 Tetracyclins 
 Quinolones-Ciprofloxacin,Ofloxacin,etc. 
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METHODOLOGY 
 
The material for this study comprises of patients admitted in Rajiv 
Gandhi Govt general hospital in the institute of general surgery from june 2017 
to September 2018. During this period 100 cases admitted for minor surgeries 
and 100 cases admitted for major surgeries were selected for study purpose. 
 
METHODS: 
This study involves all minor and major surgeries meeting up the 
inclusion and exclusion criteria. Minor surgery cases were labeled as group A 
of which those study group who receives only single dose of antibiotic prior to 
incision was labeled as A1 and control group who receives conventional 5 day 
post op course of antibiotic were labeled as A2. Similarly Major surgery cases 
were labeled as group B of which study group who receives 3 doses of 
antibiotic, one prior to incision , 2nd dose 8 hrs later and 3rd dose 8 hours after 
2nd dose were labeled as B1 and control group who receives conventional 5 
days post op antibiotics were labeled as B2. 
Minor surgery cases were labeled as those cases that needs admission and 
operated under anesthesia and surgery that lasts less than one hour, for which 
conventional 5 day antibiotic was given regularly in our hospital. Major 
surgeries are labeled as those cases that operated more than one hour. 
On admission to the hospital, a detailed proforma was completed which 
includes the diagnosis, Pre-op investigations and meticulous Pre-operative 
patient preparation. All the patients were followed up to ten days post 
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operatively. Data was entered in the proforma. Wound swabs were sent for 
culture and sensitivity in the infected cases and the results were compared and 
studied. Patients were admitted on our out-patient days. Patients were 
categorized as minor or major cases depending on their complaints, clinical 
examination and diagnosis. Patients were informed regarding the study and 
consent was taken.  All patients were admitted 2 days prior to surgery after 
getting thoroughly investigated and also some special investigations in selected 
cases to clinch the diagnosis was performed. Preoperative hospital stay was 
minimized to prevent the patient from getting the access to hospital infections. 
Pre operative skin preparation was done meticulously. Patients allowed to 
take through scrub both after which parts were prepared with Povidone Iodine 
and was isolated from the surrounding by covering operative site by sterile 
gauze. Patients were brought to the waiting room next day morning and were 
given single dose of iv.Ceftriaxone 1gm under aseptic precaution half an hour 
before the surgery for both minor and major surgeries. All the cases were done 
in the morning hours. Patients were anaesthetized under aseptic precaution. 
Sterile gauze was removed and patient’s skin was painted with povidone iodine 
solution and sprit. Then the surface was allowed to dry. Then it was covered 
with sterile towels and sheets. Surgery was performed by senior staff and 
postgraduates, whenever possible, cautery was minimized. Movement in the 
operating room was restricted. Whenever necessary closed suction drain was 
preferred and wound was closed with sterile dressings. 
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Patients were isolated in the postoperative ward for atleast 3 days. Major 
surgery cases were given another 2 doses of antibiotics at 8 hours interval. 
Wound was inspected on third day, any sign of Inflammation, Infection were 
noted down and findings were entered in the Proforma. Southampton scoring 
system was applied for infected wounds. If infected, wound swab was taken 
and sent for culture and sensitivity and Antibiotic was started immediately in 
all Infected cases   .Sutures were removed immediately in all infected cases 
.Patients were followed up to 30th  post operative day. All the data was entered 
in the proforma. The available results and outcomes in both groups were 
studied and analyzed and then were compared with the available previous study 
and final conclusion was drawn. 
 
INCLUSION CRITERIA: 
- Routine clean minor and major cases 
- Serum albumin >3.5 
- Hb > 10 gm% 
- Age  20- 60 
- Prophylactic antibiotic administered single dose prior to incision for clean 
minor surgeries 
- 3 dose antibiotic 1st dose prior to incision , 2nd dose 8 hours later, 3rd dose 8 
hours after 2nd dose in clean major surgeries  
EXCLUSION CRITERIA: 
- Emergency caeses 
49 
 
- Serum albumin <3.5 
- Hb < 10 gm% 
- Age <20 , >60 
- Associated  comorbid conditions like hypertension,diabetes and infection in 
any other part of the body.  
 
Southampton Scoring System: 
 
GRADE  
0 Normal healing 
1 Bruising and mild erythema 
2 Erythema and signs of 
inflammation 
3 Clear (or) serous discharge 
4 Pus formation 
5 Deep, severe wound infection 
 
   Table 2: Southampton score 
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RESULTS 
The study involves 100 minor surgery cases and 100 major surgery 
cases  admitted in general surgical wards in Rajiv Gandhi govt general hospital. 
Minor surgery cases were labeled as group A of which those study group who 
receives only single dose of antibiotic prior to incision was labeled as A1 and 
control group who receives conventional 5 day post op course of antibiotic 
were labeled as A2. Similarly Major surgery cases were labeled as group B of 
which study group who receives 3 doses of antibiotic, one prior to incision , 2nd 
dose 8 hrs later and 3rd dose 8 hours after 2nd dose were labeled as B1 and 
control group who receives conventional 5 days post op antibiotics were 
labeled as B2. 
MINOR SURGERY CASES: 
AGE DISTRIBUTION: 
 
Table 3:Age distribution of minor cases 
 
 
CHARACTERISTICS 
A1 (n=50) 
Study group 
A2 (n=50) 
control 
 
P value N % N % 
 
 
AGE(in 
years) 
20 – 29 18 36.0 7 14.0  
 
p>0.05 
30 – 39 9 18.0 18 36.0 
40 – 49 13 26.0 11 22.0 
50 and 
above 
10 20.0 14 28.0 
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                    Fig 4 : Age distribution of minor cases 
 
  
Group A1 
(study group) 
Group A2 
(control) 
No of 
cases 
infected % 
No of 
cases 
infected % 
 
 
 
Age in 
years 
20 -29 18 - - 7 - - 
30-39 9 - - 18 1 5.55 
40-49 13 2 15.0 11 1 9.09 
50 
&above 
10 - - 14 - - 
 
Total 
50 
 
2 
 
4.0 
 
50 
 
2 
 
4.0 
 
 
Table 4:Age distribution of  infected cases 
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                            Fig 5:   Incidence in minor case 
Incidence rate: 
 Infected Not infected Incidence 
A1(study) 2 48 4.0% 
A2(control) 2 48 4.0% 
                
                                     Table 5:Incidence of minor cases 
Of the 50 cases in study group 2 cases were infecteted and was in age group 
40-49. In control group 2 of 50 cases were infected and was in age group 30-39 
and 4- 49. The incidence in study group was 4% and incidence in control group 
was also 4%. 
 A1 study A2 control P value 
Age 36±12.1 
 
40±9.8 
 
p>0.05 
Table 6 : Average age distribution 
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Sex distribution : 
 
Sex A1(study group) A2(control)  
P value n % n % 
Male 24 48.0 34 68.0  
p>0.05 Female 26 52.0 16 32.0 
   
Table 7 : Sex distribution of minor cases 
 
 
  Fig 6 : Sex distribution of minor cases 
 
In study group 48% were male and 52% were females whereas in 
control group 68% were males and 32% were females. 
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Anaesthesia:  
 A1(study) A2(control) P value 
N % n % 
General 23 46.0 5 10.0 p>0.05 
Local 2 4.0 2 4.0 
Spinal 25 50.0 43 86.0 
 
              Table 8 : Anaesthesia of minor cases 
 
 
                                 Fig 7 :  Anaesthesia of minor cases 
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Causative organism: 
 
 
    Fig 8 : CAUSATIVE ORGANISM 
 A1(study) A2(control) 
Not infected 48 48 
Staph aureus 2 2 
 
Table 9 : Causative organism 
2 cases of 50 were infected in the study group and 2 of 50 cases were 
infected in control group. All infected cases in both the groups was due to 
staphylococcus aureus. 
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Postop complications: 
 Fever Serous discharge Pus discharge 
A1(study) 2 2 0 
A2(control) 2 2 0 
 
 
 
Male 
Feve
r +ve 
serous 
Discharg
e 
Pus 
Discharg
e 
Femal
e 
Feve
r +ve 
serous 
Discharg
e 
Pus 
Discharg
e 
Case 24 0 0 0 26 2 2 0 
Contr
ol 
34 1 1 0 16 1 1 0 
                     
Table 10 :  Postop complications in minor case 
 
 
  Fig 9 : Postop complications in minor cases 
 
 
Male Fever
+ve
serous
Dis
Pus
Disch
Female Fever
+ve
serous
Dis
Pus
Disch
24
0 0 0
26
2 2
0
34
1 1
0
16
1 1
0
Minor
Case
Control
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MAJOR SURGERY CASES: 
Age distribution: 
 
   Table 11 : Age distribution of major cases 
 
 
Fig 10 : Age distribution of major cases 
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CHARACTERISTICS 
B1 (n=50) 
Study group 
B2 (n=50) 
control 
 
P value N % N % 
 
 
AGE(in 
years) 
20 – 29 12 24.0 11 22.0  
 
p>0.05 
30 – 39 6 12.0 17 34.0 
40 – 49 17 34.0 10 20.0 
50 and 
above 
15 30.0 12 24.0 
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                Group B1 
               (study group) 
                Group B2 
                 (control) 
No of 
cases 
infected % 
No of 
cases 
infected % 
 
 
 
Age in 
years 
20 -29 12 - - 11 - - 
30-39 6 - - 17 - - 
40-49 17 2 11.7 10 1 10.0 
50 
&above 
15 1 6.66 12 1 8.33 
 
Total 
50 3 6.0 50 2 4.0 
 
Table 12 : INCIDENCE IN MAJOR CASES 
Of the 50 cases in study group 3 cases were infecteted and 2 was in age group 
40-49 and one case 50 years of age. In control group 2 of 50 cases were 
infected and was in age group 30-49 and above 50. The incidence in study 
group was 6% and incidence in control group was also 4%. 
  B1(study) B2(control)  
       P value n % n % 
 
SSI 
Infected 3 6.0 2 4.0         
         P>0.05 Not 
infected 
47 94.0 48 96.0 
   Table 13 : incidence in major cases 
          Infected       Not infected Incidence  
B1(study) 3 47 6.0% 
B2(control) 2 48 4.0% 
Table : 14 Incidence in major cases 
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Fig 11 : Incidence in major cases 
 
 B1 study B2 control P value 
Age 
 
42±10.7 
 
 
38±12.6 
 
 
p>0.05 
   Table 15 : Average age distribution in major cases 
Sex distribution: 
 
Sex B1(study group) B2(control)  
P value N % N % 
Male 11 22.0 16 32.0  
p>0.05 Female 39 78.0 34 68.0 
     
Table 16 : Sex distribution major 
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    Fig 12 : Sex distribution major 
 
In study group 22% were male and 78% were females whereas in control group 
32% were males and 68% were females. 
 
Anaesthesia in major cases: 
 
 B1(study) B2(control) P value 
n % n % 
General 41 82.0 49 98.0 p>0.05 
Spinal 9 18.0 1 2.0 
 
   Table 17 : Anaesthesia in major cases 
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   Fig 13 : Anaesthesia in major cases 
Causative organism: 
 
   Fig 14 : Causative organisms in major cases 
 
 B1(study) B2(control) 
Not infected 47 48 
Staph aureus 3 1 
pseudomonas 0 1 
   Table 18 : Causative organism in major cases 
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3 of 50 cases in study group were infected and culture of all 3 cases was 
staphylococcus aureus. In control group 2 of 50 cases were infected and culture 
report was staph aureus 1 case and pseudomonas 1 case. 
Postop complications : 
 
 
Male 
Fever 
+ve 
serous 
Discharge 
Pus 
Discharge 
Female 
Fever 
+ve 
serous 
Discharge 
Pus 
Discharge 
Case 11 0 0 0 39 3 3 0 
Control 16 0 0 0 34 2 1 1 
         
             
Table 19 : Postop complications in major 
 
 Fever Serous discharge Pus discharge 
B1(study) 3 3 0 
B2(control) 2 2 1 
    
Table 20 : Postop complications major 
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DISCUSSION 
Surgical site infection has been documented ever since the origin of 
surgery, has not been mastered. Its incidence can be reduced by strict asepsis , 
meticulous surgical techniques, prophylactic antibiotic have drastically reduced 
the incidence of SSI. 
This study involves minor and major surgery cases in rajiv Gandhi govt 
general hospital, both were divided to study and control group with each 50 
cases in it. 
Study group in minor received single dose of inj.ceftriaxone 1 gm half 
an hour prior to incision and study group of major cases received 1gm of 
ceftriaxone half an hour before incision, 2nd and 3rd doses with 8 hours of 
interval. Control groups in both minor and major cases received routine 5 day 
course of inj . ceftriaxone 1gm bd and inj. Metronidazole 500 mg tds. Wound 
of all the patients were looked for signs of infection and analysis done with the 
data collected. For infected cases antibiotic was started immediately and swab 
for culture sent. 
Age incidence: 
 Though surgical site infection affects all age group its incidence 
increases with age and is seen frequently in old age. In this study incidence of 
infection occurs mostly above 40 years of age in both minor and major 
surgeries. 
In this study in minor surgeries incidence of infection is higher in age 
group between 38-50 . in major surgeries incidence of infection is more in age 
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group 40-55. Hence this study also shows that incidence of infection increases 
with age. 
 
Sex distribution: 
 There is more number of female cases in this study than male. In minor 
surgeries 3 male cases and 1 female case is infected out of 100 cases. In major 
surgeries all 5 infected cases were females. There is no evidence that 
supporting the fact that females are most infected than males. 
  Not Infected Infected 
Case 
 
Male 11 0 
Female 39 3 
Control 
 
Male 16 0 
Female 34 2 
 
Table 21 : Major cases sex distribution with infection 
 
Fig 15 : Major case sex distribution 
 
 
Male Female Male Female
Case Control
11
39
16
34
0
3
0 2
Major - Sex wise
Not Infected
Infected
65 
 
  
Not Infected Infected 
Case 
Male 24 2 
Female 26 0 
Control 
Male 34 1 
Female 16 1 
 
Table 22 : Minor case sex distribution 
 
 
   Fig 16 : Minor case sex distribution 
Culture: 
  Culture was sent for all infected cases. All 4 infected cases 
in minor surgeries were positive for staphylococcus aureus . out of 5 
infected cases in major surgeries 4 were infected by staphylococcus 
aureus , 1 was infected by pseudomonas. Both of  the organisms are 
hospital strains and staph was sensitive to cephalosporins and 
ciprofloxacin . pseudomonas was sensitive to levofloxacin and 
piperacillin. 
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Incidence:  
 4%  minor cases in study group were infected and 4% of control 
group was infected. In major surgeries 6% of cases were infected in study 
group and 4% of cases in control groups were infected. There is no much 
significant difference in incidence between study group and control group 
in both major and minor surgeries. 
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CONCLUSION 
 This study is one of the most important facets in general surgery. The 
study on single dose and triple dose antibiotic in minor and major surgeries has 
led me to this conclusion. 
 Surgical site infection is the condition that may increase the morbidity and 
hospital stay of the patient. In severe cases may lead to loss of hospital 
resources, emergence of resistant bacteria, or may even lead to death of the 
patient due to sepsis. 
 Its incidence increases with increasing age group, old age patients are the most 
affected. 
 Risk factors for development of SSI should be identified and patient factors 
like anemia, DM are to be corrected prior to surgery. 
 Local factors and microbial factors should be kept in mind and necessary steps 
to be taken to avoid them.  
 When SSI is identified, wound swab to be sent to culture and appropriate 
antibiotics should be started early. 
 Adequate drainage of pus should be done in case of severe infection by 
removing  one or two sutures and secondary suturing to be done after infection 
control. 
 SSI with hospital acquired infection should be reduced by proper nursing care 
and proper maintenance of surgical wards. 
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 For minor surgeries administration of single dose of antibiotic prior to surgery 
is enough rather than five days of antibiotic as there is much difference in 
incidence of infection. 
 For major surgeries 3 doses of antibiotic 1st dose starting just prior to surgery 
and other 2 doses with 8 hours of interval is sufficient that 5 days of antibiotic 
as there is no significant difference in incidence of infection. 
 Misuse of antibiotics should be reduced as it leads to increased cost, depletion 
of hospital resources , increased resistance and side effects of drugs. 
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SUMMARY 
 This study was done to compare the outcome of single dose of antibiotic vs 
routine 5 days antibiotic in preventing SSI in minor surgeries. And compare 
outcome of  3 dose antibiotic vs 5 day antibiotic in major surgeries. 
 100 minor surgery cases were selected and grouped in to a study group and 
control group with 50 cases each. Similarly 100 major surgery cases was 
selected and grouped into study and control group with 50 cases each. 
 In minor surgery cases study group was administered single dose of iv 
inj.ceftriaxone 1 gm prior to surgery prophylactically. 
 In major surgery study group was administered with 1gm iv ceftriaxone 1st 
dose prior to surgery and other 2 doses with 8 hours of  interval. 
 Control groups in both the cases were administered with 5 days of postop 
antibiotic with inj.ceftriaxone 1gm bd and inj.metronidazole 500mg tds. As this 
antibiotic protocol is routinely administered in our institution. 
 In minor surgery  4 cases got infected and swab for culture sent and was 
positive with staph aureus 
 In major surgeries 5 cases were infected , 4 were infected with staph aureus and 
one with pseudomonas. Both these organisms are nosocomial organisms. 
 Infected cases were started immediately with appropriate antibiotics. 
 Age is a variable for surgical site infection where incidence increases with age. 
 For minor cases infection rate in study group was 4% and in control group is 
4%  and hence there is no much significant difference. 
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 For major surgery infection rate in study group is 6% and in control group is 
4%. 
 To prevent surgical infection logical investigation of the underlying source of 
infection , anticipation and adherence to sound principles governing antibiotic 
prophylaxis and treatment should be employed. 
 To summarize from the present study on analysis 
 Single dose of preoperative antibiotic in minor surgeries and 3 dose of 
antibiotic in major surgeries is a sufficient powerful tool to fight against  
postop surgical site infection. 
 It should be stressed that careful surgical techniques, which include gentleness 
in tissue handling, preservation of vascularity, ideal hemostasis , removal of 
devitalised tissue and foreign particles is a must in every surgery. 
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PROFORMA 
“COMPARITIVE STUDY OF EFFICACY OF SINGLE DOSE 
ANTIBIOTIC IN MINOR ,  TRIPLE DOSE ANTIBIOTIC IN MAJOR 
SURGERIES VS ROUTINE POST OPERATIVE ANTIBIOTIC 
THERAPHY IN CLEAN MINOR AND MAJOR SURGERIES“ 
 
Name of the patient: 
Age: 
Sex: 
Religion: 
Address: 
Occupation: 
DOA: 
DOD: 
Hospital stay: 
Brief Clinical History: 
Past History:H/O DM/HTN/UTI/URI/TB/Jaundice: 
Personal History:    Veg/Non-Veg 
       Smoker/Non-Smoker: 
Socio-Economic Status:   Poor  /  Lower Middle class   / Upper Middle 
Class/Rich 
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GENERAL PHYSICAL EXAMINATION: 
Poorly built   /   Moderately built     /    Well built 
Pulse rate:    BP:   RR: 
Systemic Examination:   PA: 
     CVS: 
     RS: 
     CNS: 
Loco Regional Examination: 
Per Rectal Examination: 
Diagnosis: 
Proposed Surgical procedure and date: 
INVESTIGATIONS: 
Hb    RBS    USG Abdomen 
TC    DC    FNAC  
BT    Urea    CXR 
CT    Creatinine   Urine Routine 
ESR   LFT    HIV/HBSAg 
Risk Factors for Surgical site infection:      Present      /     Absent 
If Present: 
Single Dose Pre-operative Antibiotic:       Given    /     not given 
Pre-operative Skin preparation:      Done     /    Not Done 
Drain:   Kept   /   Not kept 
Duartion of Surgery: 
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Immediate Post-operative period:  Eventful  /   Uneventful 
Hemorrhage   /   Fever    /  Cough  /  URTI / UTI  / Others 
Removal of Drain: 
Nature of Wound: On 3rd day –  
     On 8th day – 
Suture Removed: 
IF infected, wound swab sent for culture  & Sensitivity:  YES   /  NO 
Organism Cultured: 
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PATIENT CONSENT FORM 
STUDY TITLE: 
“COMPARITIVE STUDY OF EFFICACY OF SINGLE DOSE 
ANTIBIOTIC IN MINOR ,  TRIPLE DOSE ANTIBIOTIC IN MAJOR 
SURGERIES VS ROUTINE POST OPERATIVE ANTIBIOTIC 
THERAPHY IN CLEAN MINOR AND MAJOR SURGERIES“ 
STUDY CENTRE: 
Rajiv Gandhi Government General Hospital and Madras Medical College. 
Participant Name:   Age:  Sex:  IP no: 
 
I confirm that I have understood the puropose of interventional procedure for 
the above study.I have the opportunity to ask the question and all my questions 
and doubts have been answered to my satisfaction. 
I have been explained about the possible complications that may occur during 
the Interventional procedure.I understand that my participation in the study is 
voluntary and free to withdraw at any time without giving any reason. 
I understand that the Investigator, Regulatory Authorities and the Ethics 
Committee will not need my permission to look at my Health Records both in 
respect to the current study and any further research that may be conducted in 
relation to it, even if I withdraw from the study. 
I understand that my Identity will not be revealed to any any third parties or 
published, unless as required under the law. I agree not to restrict the use of any 
data or Results that arise from the study. 
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I hereby consent to participate in this study of the “COMPARITIVE STUDY 
OF EFFICACY OF SINGLE DOSE ANTIBIOTIC IN MINOR ,  TRIPLE 
DOSE ANTIBIOTIC IN MAJOR SURGERIES VS ROUTINE POST 
OPERATIVE ANTIBIOTIC THERAPHY IN CLEAN MINOR AND MAJOR 
SURGERIES“. 
 
 
 
      Signature/Thumb Impression of the 
patient. 
Date: 
Place: 
Patient’s Name: 
 
Signature of the Investigator: 
Name of the Investigator: 
 
 
 
 
 
 
 
82 
 
INFORMATION SHEET 
We are conducting a study on “COMPARITIVE STUDY OF EFFICACY 
OF SINGLE DOSE ANTIBIOTIC IN MINOR ,  TRIPLE DOSE 
ANTIBIOTIC IN MAJOR SURGERIES VS ROUTINE POST 
OPERATIVE ANTIBIOTIC THERAPHY IN CLEAN MINOR AND 
MAJOR SURGERIES“ among patients attending Rajiv Gandhi Government 
General Hospital, Chennai and for that your Information is valuable for us. 
The purpose of the study is to assess the efficacy of single dose and triple dose 
Antibiotic with routine Antibiotic therapy. We are selecting certain cases and if 
you are found eligible we may be using your information which in anyway 
don’t affect your final report or management. 
The privacy of the patients in the research will be maintained throughout the 
study. In the event of any publication or presentation resulting from the 
research, no personally identifiable information will be shared. 
Taking part in the study is voluntary. You are free to decide whether to 
participate in the study or to withdraw at any time. 
Your decision will not result in any loss of benefits to which you are otherwise 
entitled. The results of the special study may be intimated to you at the end of 
the study period or during the study if anything is found abnormal which may 
aid in the management or treatment. 
 
     
 
Signature / Thumb Impression of the patient: 
 
 
Signature of the Investigator: 
 
Date: 
 
Place: 
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MASTER SHEET – Major Cases. 
S.
N
O 
NAME 
A
G
E 
S
E
X 
IP 
NU
MBE
R 
DIAGNOSIS 
GRO
UP 
PROCEDURE 
ANA
EST
HESI
A 
INFEC
TION 
STAT
US 
CULTU
RE  
SOUT
HAM
PTON 
SCOR
E 
FEVE
R 
SERO
US 
DISC
HARG
E 
PUS 
DISC
HARG
E 
1 
VENDA 41 F 866 
SOLITARY NODULE 
THYROID 
B1 
TOTAL 
THYROIDECTOMY 
GA 2 nil 
0 2 2 2 
2 
LAKSHMI 50 F 
134
235 
CHOLELITHIASIS B1 
LAP 
CHOLECYSTECTOMY 
GA 2 nil 
0 2 2 2 
3 
HEMAMA
LINI 
27 F 
242
3 
SUBACUTE 
APPENDICITIS 
B1 
LAP 
APPENDICECTOMY 
GA 2 nil 
0 2 2 2 
4 
VIVEK 
LAKSHMI
KANTH 
47 M 
138
903 
VENTRAL HERNIA B1 MESH REPAIR GA  2 nil 
0 2 2 2 
5 
THURAIVI
KALAN 
55 M 
132
975 
SOFT TISSUE 
SARCOMA RT BACK 
B1 
LOCAL EXCISION 
WITH 
RECONSTRUCTION 
GA 2 nil 
0 2 2 2 
6 
JAYATHI 42 F 
124
576 
CHOLEDOCHOLITHIA
SIS WITH 
CHOLELITHIASIS 
B1 
OPEN 
CHOLECYSTECTOMY 
WITH OPEN CBD 
EXPLORATION 
GA 2 nil 
0 2 2 2 
7 
INDRANI 54 F 
309
24 
PLEOMORPHIC 
ADENOMA 
B1 
SUPERFICIAL 
PAROTIDECTOMY 
GA 2 nil 
0 2 2 2 
8 
DHARANI 50 F 
390
19 
CHOLEDOCHOLITHIA
SIS WITH 
CHOLELITHIASIS 
B1 
OPEN 
CHOLECYSTECTOMY 
WITH OPEN CBD 
EXPLORATION 
GA 2 nil 
0 2 2 2 
9 
VINAYAG
AM 
40 M 
408
92 
RETROPERITONEAL 
TUMOR  
B1 EXCISION GA 2 nil 
0 2 2 2 
10 
MANJULA 42 F 
452
52 
CA BREAST B1 MRM GA 2 nil 
0 2 2 2 
11 
SUDHA 30 F 
473
06 
CHOLELITHIASIS B1 
LAP 
CHOLECYSTECTOMY 
GA 2 nil 
0 2 2 2 
12 
VELVIZHI 21 F 
474
47 
SUBACUTE 
APPENDICITIS 
B1 
LAP 
APPENDICECTOMY 
GA 2 nil 
0 2 2 2 
13 
VINCENT 49 M 
446
20 
SOLITARY NODULE 
THYROID 
B1 
TOTAL 
THYROIDECTOMY 
GA 2 nil 
0 2 2 2 
14 
DHIVYA 26 F 
521
22 
CA THYROID B1 
TOTAL 
THYROIDECTOMY 
GA 2 nil 
0 2 2 2 
15 
SELVAMA
NI 
40 F 
525
44 
MNG THYROID B1 
TOTAL 
THYROIDECTOMY 
GA 2 nil 
0 2 2 2 
16 
NITHYA 29 F 
511
07 
CHRONIC 
APPENDICITIS 
B1 
LAP 
APPENDICECTOMY 
GA 2 nil 
0 2 2 2 
17 
SHANTHI 40 F 
501
16 
CA BREAST B1  MRM GA 
1 
STAPH 
AUREU
S 3 1 
1 
2 
18 
DHANALA
KSHMI 
52 F 
447
19 
INCISIONAL HERNIA B1 MESH REPAIR 
SPIN
AL 
2 nil 
0 2 2 2 
19 
RAJA 25 M 
597
22 
INCISIONAL HERNIA B1 MESH REPAIR 
SPIN
AL 
2 nil 
0 2 2 2 
20 
ANANDH
ALAKSHM
I 
50 F 
665
67 
CA BREAST B1 MRM GA 2 nil 
0 2 2 2 
21 
VALLIYAM
MAL 
56 F 
609
63 
INCISIONAL HERNIA B1 MESH REPAIR 
SPIN
AL 
2 nil 
0 2 2 2 
22 
NATARAJ 55 M 
568
67 
PLEOMORPHIC 
ADENOMA 
B1 
SUPERFICIAL 
PAROTIDECTOMY 
GA 2 nil 
0 2 2 2 
23 
AMMU 29 F 
597
67 
CA BREAST B1 MRM GA 2 nil 
0 2 2 2 
24 
KAMALA 45 F 
530
20 
CA THYROID B1 
TOTAL 
THYROIDECTOMY 
GA 2 nil 
0 2 2 2 
25 
MANISHA
MMAL 
40 F 
617
13 
SOLITARY NODULE 
THYROID 
B1 
TOTAL 
THYROIDECTOMY 
GA 2 nil 
0 2 2 2 
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26 
VIJAYA 52 F 
644
03 
CHOLELITHIASIS B1 
LAP 
CHOLECYSTECTOMY  
GA 2 nil 
0 2 2 2 
27 
DURGADE
VI 
42 F 
642
81 
INCISIONAL HERNIA B1 MESH REPAIR 
SPIN
AL 
1 
STAPH 
AUREU
S 3 1 
1 
2 
28 
THULASIA
MMAL 
50 F 
613
47 
CA BREAST B1 MRM GA 2 nil 
0 2 2 2 
29 
DEVI 36 F 
645
67 
INCISIONAL HERNIA B1 MESH REPAIR 
SPIN
AL 
2 nil 
0 2 2 2 
30 
KOUSHIK
A BEGAM 
45 F 
628
31 
INCISIONAL HERNIA B1 MESH REPAIR 
SPIN
AL 
2 nil 
0 2 2 2 
31 
MENAKA 40 F 
669
41 
SUBACUTE 
APPENDICITIS 
B1 
OPEN 
APPENDICECTOMY 
SPIN
AL 
2 nil 
0 2 2 2 
32 
ANANDH
ALAKSHM
I 
50 F 
665
67 
CA BREAST B1 MRM LA 
1 
STAPH 
AUREU
S 3 1 
1 
2 
33 
JAYAMM
A 
25 F 
653
25 
CA BREAST B1 MRM GA 2 nil 
0 2 2 2 
34 
MEGALA 30 F 
735
08 
SUBACUTE 
APPENDICITIS 
B1 
LAP 
APPENDICECTOMY 
GA 2 nil 
0 2 2 2 
35 
JAYALAKS
HMI 
44 F 
712
83 
INCISIONAL HERNIA B1 MESH REPAIR GA 2 nil 
0 2 2 2 
36 
INDIRA 
GANDHI 
53 F 
727
26 
INCISIONAL HERNIA B1 MESH REPAIR GA 2 nil 
0 2 2 2 
37 
KANDAVE
L 
37 F 
709
93 
CHOLEDOCHOLITHIA
SIS 
B1 
CBD 
EXPLORATION/HEPA
TICOJEJUNOSTOMY 
GA 2 nil 
0 2 2 2 
38 
DHANALA
KSHMI 
29 F 
747
03 
SOLITARY NODULE 
THYROID 
B1 
TOTAL 
THYROIDECTOMY 
GA 2 nil 
0 2 2 2 
39 
FAIZAL 25 M 
787
41 
CHOLELITHIASIS B1 
LAP 
CHOLECYSTECTOMY 
GA 2 nil 
0 2 2 2 
40 
VIGNESH 28 M 
789
41 
SUBACUTE 
APPENDICITIS 
B1 
LAP 
APPENDICECTOMY 
GA 2 nil 
0 2 2 2 
41 
VENKATE
SAN 
45 M 
707
63 
SOFT TISSUE 
SARCOMA RIGHT 
FOREARM 
B1 
WIDE LOCAL 
EXCISION/SSG/FLAP 
RIGHT AXILLARY 
NODE DISSECTION 
GA 2 nil 
0 2 2 2 
42 
SHALINI 20 F 
816
52 
SUBACUTE 
APPENDICITIS 
B1 
LAP 
APPENDICECTOMY 
GA 2 nil 
0 2 2 2 
43 
SUNDAR 50 F 
788
30 
INCISIONAL HERNIA B1 MESH REPAIR GA 2 nil 
0 2 2 2 
44 
GOVINTH
AMMAL 
55 F 
780
66 
CHOLEDOCHOLITHIA
SIS WITH 
CHOLELITHIASIS 
B1 
OPEN 
CHOLECYSTECTOMY 
WITH OPEN CBD 
EXPLORATION 
GA 2 nil 
0 2 2 2 
45 
GOWRI 37 F 
798
41 
VENTRAL HERNIA B1 MESH REPAIR GA 2 nil 
0 2 2 2 
46 
GIRIJA 38 F 
770
52 
SCC IN SCALP B1 
WLE+ FLAP COVER + 
RIGHT POSTERD 
LAT.NECK 
DISSECTION 
GA 2 nil 
0 2 2 2 
47 
VIJAYAKU
MAR 
48 M 
827
06 
RIGHT SOFT TISSUE 
SARCOMA 
B1 REEXICISION GA 2 nil 
0 2 2 2 
48 
ASHOKAN 53 M 
799
44 
INCISIONAL HERNIA B1 MESH REPAIR GA 2 nil 
0 2 2 2 
49 
CHITRA 20 F 
850
98 
PSEUDO PAPILLARY 
CYSTIC NEOPLASM 
OF NEOPLASM OF 
PANCREAS 
B1 
DISTAL 
PANCREATOMY 
WITH 
SPLEENECTOMY 
GA 2 nil 
0 2 2 2 
50 
VEERAM
MAL 
45 F 
885
62 
INCISIONAL HERNIA B1 MESH REPAIR 
SPIN
AL 
2 nil 
0 2 2 2 
1 
SIVAGAMI 35 F 
942
81 
CHOLELITHIASIS B2 
LAP 
CHOLECYSTECTOMY  
GA 2 nil 
0 2 2 2 
2 
PRAMAIA
H 
34 M 
975
80 
CHOLELITHIASIS B2 
LAP 
CHOLECYSTECTOMY  
GA 2 nil 
0 2 2 2 
85 
 
3 
MAHESH 
KUMAR 
27 M 
989
60 
SUBACUTE 
APPENDICITIS 
B2 
LAP 
APPENDICECTOMY 
GA 2 nil 
0 2 2 2 
4 
IYYANAR 55 M 
967
41 
VENTRAL HERNIA B2 MESH REPAIR GA 2 nil 
0 2 2 2 
5 
JAMUNA 30 F 
970
73 
INCISIONAL HERNIA B2 MESH REPAIR GA 2 nil 
0 2 2 2 
6 
RANI 45 F 
946
49 
EPIGASTRIC 
HERNIA/LEFT 
INGUINAL HERNIA 
B2 IPOM + TAPP GA 2 nil 
0 2 2 2 
7 
RAJASEKA
RAN 
58 M 
969
02 
MNG THYROID B2 
TOTAL 
THYROIDECTOMY 
GA 2 nil 
0 2 2 2 
8 
KANIMOZ
HI 
30 F 
104
160 
MNG THYROID B2 
TOTAL 
THYROIDECTOMY 
GA 2 nil 
0 2 2 2 
9 
RAJALAKS
HMI 
34 F 
102
634 
CHOLELITHIASIS B2 
LAP 
CHOLECYSTECTOMY  
GA 2 nil 
0 2 2 2 
10 
KAMARAJ 31 M 
103
115 
COMPLETE RECTAL 
PROLAPSE 
B2 
ABDOMINAL 
RECTOPEXY 
GA 2 nil 
0 2 2 2 
11 
LAKSHMI 53 F 
103
643 
MNG THYROID B2 
TOTAL 
THYROIDECTOMY 
GA 2 nil 
0 2 2 2 
12 
SANGEET
HA 
36 F 
105
170 
SOLITARY NODULE 
THYROID 
B2 
TOTAL 
THYROIDECTOMY 
GA 2 nil 
0 2 2 2 
13 
LAKSHMI 53 F 
103
643 
MNG THYROID B2 
TOTAL 
THYROIDECTOMY 
GA 2 nil 
0 2 2 2 
14 
JEGAN 22 M 
110
644 
SUBACUTE 
APPENDICITIS 
B2 
LAP 
APPENDICECTOMY 
GA 2 nil 
0 2 2 2 
15 
LAKSHMI 40 F 
303
9 
INCISIONAL HERNIA B2 MESH REPAIR GA 2 nil 
0 2 2 2 
16 
BALAMUR
UGAN 
26 M 
294
5 
SUBACUTE 
APPENDICITIS 
B2 
LAP 
APPENDICECTOMY 
GA 2 nil 
0 2 2 2 
17 
MANIKAV
ALLI 
54 F 
118
7 
CHOLELITHIASIS B2 
LAP 
CHOLECYSTECTOMY  
GA 2 nil 
0 2 2 2 
18 
VASANTHI 40 F 
137
773 
CA BREAST B2 MRM GA 
1 
STAPH 
AUREU
S 3 1 
1 
2 
19 
KRISTAM
MAL 
38 F 
175
86 
CA BREAST B2 MRM GA 2 nil 
0 2 2 2 
20 
DEEPA 25 F 
206
17 
CHOLELITHIASIS B2 
LAP 
CHOLECYSTECTOMY  
GA 2 nil 
0 2 2 2 
21 
RAVALIDE
VI 
36 F 
216
61 
CHOLELITHIASIS  B2 
LAP 
CHOLECYSTECTOMY  
GA 2 nil 
0 2 2 2 
22 
RATHINA
MMAL 
40 F 
166
50 
CA BREAST B2 MRM GA 2 nil 
0 2 2 2 
23 
MANGAL
AM 
58 F 
251
95 
INCISIONAL HERNIA B2 MESH REPAIR GA 2 nil 
0 2 2 2 
24 
LAKSHMI 36 F 
198
00 
SUBACUTE 
APPENDICITIS 
B2 
LAP 
APPENDICECTOMY 
GA 2 nil 
0 2 2 2 
25 
PADMAV
ATHY 
42 F 
919
00 
INCISIONAL HERNIA B2 MESH REPAIR GA 2 nil 
0 2 2 2 
26 
PUITHAV
ALLI 
23 F 
258
15 
SUBACUTE 
APPENDICITIS 
B2 
LAP 
APPENDICECTOMY 
GA 2 nil 
0 2 2 2 
27 
VIJAYA 38 F 
280
83 
PLEOMORPHIC 
ADENOMA 
B2 
SUPERFICIAL 
PAROTIDECTOMY 
GA 2 nil 
0 2 2 2 
28 
VIJAY 25 F 
368
89 
SUBACUTE 
APPENDICITIS 
B2 
LAP 
APPENDICECTOMY 
GA 2 nil 
0 2 2 2 
29 
GOVINDA
MMAL 
55 F 
319
79 
RIGHT FOOT 
MALIGNANT 
MELANOMA 
B2 
WLE + FLAP COVER+ 
RIGHT ILIO 
INGUINAL BLOCK 
DISSECTIONWITH 
TENSOR FASCIA 
RECONSTRUCTION 
GA 
1 
PSEUD
OMON
AS +VE 
4 
1 2 
1 
30 
KIRAN 
KUMAR 
20 M 
374
14 
SUBACUTE 
APPENDICITIS 
B2 
LAP 
APPENDICECTOMY 
GA 2 nil 
0 2 2 2 
86 
 
31 
SATHYA 39 F 
373
11 
SUBACUTE 
APPENDICITIS 
B2 
OPEN 
APPENDICECTOMY 
SPIN
AL 
2 nil 
0 2 2 2 
32 
RAJI 41 F 
330
89 
CA BREAST B2 MRM GA 2 nil 
0 2 2 2 
33 
PADMAV
ATHY 
25 F 
401
62 
SUBACUTE 
APPENDICITIS 
B2 
LAP 
APPENDICECTOMY 
GA 2 nil 
0 2 2 2 
34 
VARADHA
N 
49 M 
340
72 
INCISIONAL HERNIA B2 MESH REPAIR GA 2 nil 
0 2 2 2 
35 
KUPPULIN
GAM 
52 M 
145
01 
ABDOMINAL WALL 
SARCOMA 
B2 
WIDE LOCAL 
EXCISION + FREE ALT 
FLAP 
GA 2 nil 
0 2 2 2 
36 
PRABAKA
RAN 
32 M 
559
07 
CHOLEDOCHOLITHIA
SIS WITH 
CHOLELITHIASIS 
B2 
OPEN 
CHOLECYSTECTOMY 
WITH OPEN CBD 
EXPLORATION 
GA 2 nil 
0 2 2 2 
37 
ZAMRUTH 
BEGUM 
51 F 
540
16 
CA BREAST B2 MRM GA 2 nil 
0 2 2 2 
38 
PONNAM
MAL 
24 F 
574
39 
SUBACUTE 
APPENDICITIS 
B2 
LAP 
APPENDICECTOMY 
GA 2 nil 
0 2 2 2 
39 
RAMANIA
H 
39 M 
506
66 
INCISIONAL HERNIA 
WITH RIGHT 
INUGINAL HERNIA 
WITH HYDROCELE 
B2 
MESH 
PLASTY/HERNIOPLA
STY/EVERSION OF 
SAC 
GA 2 nil 
0 2 2 2 
40 
PRABAKA
RAN 
32 M 
559
07 
CHOLEDOCHOLITHIA
SIS WITH 
CHOLELITHIASIS 
B2 
OPEN 
CHOLECYSTECTOMY 
WITH OPEN CBD 
EXPLORATION 
GA 2 nil 
0 2 2 2 
41 
THAIYALN
AGI 
46 F 
590
14 
CA BREAST B2 MRM GA 2 nil 
0 2 2 2 
42 
VASANTH
A 
26 F 
603
85 
MNG THYROID B2 
TOTAL 
THYROIDECTOMY 
GA 2 nil 
0 2 2 2 
43 
RADHA 32 F 
602
02 
VENTRAL HERNIA B2 MESH REPAIR GA 2 nil 
0 2 2 2 
44 
MEENA 53 F 
568
59 
CA BREAST B2 MRM GA 2 nil 
0 2 2 2 
45 
PARTHAS
ARATHY 
47 M 
603
13 
CHOLEDOCHOLITHIA
SIS WITH 
CHOLELITHIASIS 
B2 
OPEN 
CHOLECYSTECTOMY 
WITH OPEN CBD 
EXPLORATION 
GA 2 nil 
0 2 2 2 
46 
RADHA 32 F 
602
02 
VENTRAL HERNIA B2 MESH REPAIR GA 2 nil 
0 2 2 2 
47 
VASANTH
A 
26 F 
603
85 
MNG THYROID B2 
TOTAL 
THYROIDECTOMY 
GA 2 nil 
0 2 2 2 
48 
PREMAVA
THY 
58 F 
621
39 
MNG THYROID B2 
TOTAL 
THYROIDECTOMY 
GA 2 nil 
0 2 2 2 
49 
ABDUL 
JABBAN 
48 M 
595
26 
INCISIONAL HERNIA B2 MESH REPAIR GA 2 nil 
0 2 2 2 
50 
NARSAYAI
H 
75 M 
954
26 
MNG THYROID B2 
TOTAL 
THYROIDECTOMY 
GA 2 nil 
0 2 2 2 
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Master Sheet – Minor cases 
S.
N
O 
NAME 
A
GE 
S
E
X 
IP 
NUM
BER 
DIAGNOSIS 
GRO
UP 
PROCEDURE 
AN
AES
THE
SIA 
INFE
CTIO
N 
STAT
US 
CULTU
RE 
SENSI
TIVITY 
SOUT
HAMP
TON 
SCORE 
FEVE
R 
SER
OU
S 
DIS
CH
AR
GE 
PUS 
DISC
HAR
GE 
1 
KALAIVA
NI 
51 F 3239 FIBROADENOMA A1 
WIDE LOCAL 
EXCISION 
GA 2 2 0 2 2 2 
2 SHANTHI 53 F 2657 RT BREAST LUMP A1 LUMPECTOMY GA 2 2 0 2 2 2 
3 
GAVASKA
R 
35 M 
1132
3 
VARICOSE VEIN A1 
TRENDLENBERG 
PROCEDURE 
SPI
NAL 
2 2 0 2 2 2 
4 NADHIYA 23 F 
3784
6 
RIGHT CERVICAL 
LYMPHADENOPA
THY 
A1 EXCISION GA 2 2 0 2 2 2 
5 VINOTH 23 M 
1513
99 
POST TRAUMATIC 
RAW AREA RIGHT 
FOOT 
A1 SSG 
SPI
NAL 
2 2 0 2 2 2 
6 RAMESH 43 M 
3275
0 
PARAUMBILICAL 
HERNIA 
A1 MESH REPAIR 
SPI
NAL 
2 2 0 2 2 2 
7 RAMESH 43 M 
3275
0 
PARAUMBILICAL 
HERNIA 
A1 MESH REPAIR 
SPI
NAL 
2 2 0 2 2 2 
8 
ANUPAM
A 
45 F 
4351
5 
PARAUMBILICAL 
HERNIA 
A1 MESH REPAIR 
SPI
NAL 
2 2 0 2 2 2 
9 NAVYA 23 F 
4345
2 
FIBROADENOMA A1 
WIDE LOCAL 
EXCISION 
GA 2 2 0 2 2 2 
10 
MAHARA
JAN 
34 M 
4350
1 
PILONIDAL SINUS A1 
BOSCOM'S 
PROCEDURE 
SPI
NAL 
2 2 0 2 2 2 
11 THULASI 25 F 
4723
3 
PHYLLOIDES 
TUMOUR 
A1 
WIDE LOCAL 
EXCISION 
SPI
NAL 
2 2 0 2 2 2 
12 
SURESH 
KUMAR 
55 M 
4630
9 
B/L HYDROCELE A1 
B/L EVERSION OF 
SAC 
SPI
NAL 
2 2 0 2 2 2 
13 
AISHWAR
YA 
26 F 
5232
2 
FIBROADENOMA A1 
WIDE LOCAL 
EXCISION 
GA 2 2 0 2 2 2 
14 
MARIYAP
PAN 
40 M 
5219
5 
UMBILICAL 
HERNIA 
A1 MESH REPAIR 
SPI
NAL 
1 
STAPH 
AURE
US 
3 1 1 2 
15 
KALIAPPA
N 
44 M 
4110
0 
RAW AREA BACK A1 SSG GA 2 2 0 2 2 2 
16 
NESRIN 
FATHIMA 
22 F 
5408
6 
FIBROADENOMA A1 
WIDE LOCAL 
EXCISION 
GA 2 2 0 2 2 2 
17 
SAKUNTH
ALA 
25 F 
5248
3 
PHYLLOIDES 
TUMOUR 
A1 
WIDE LOCAL 
EXCISION 
GA 2 2 0 2 2 2 
18 AJAY 21 M 
5778
9 
B/L HYDROCELE A1 
B/L EVERSION OF 
SAC 
SPI
NAL 
2 2 0 2 2 2 
19 
RAJASEK
AR 
40 M 
6022
6 
LEFT VARICOSE 
VEIN 
A1 
TRENDLENBERG 
PROCEDURE 
GA 2 2 0 2 2 2 
20 
SANDHIY
A 
27 F 
6225
6 
FIBROADENOMA A1 
WIDE LOCAL 
EXCISION 
GA 2 2 0 2 2 2 
21 MUNIRAJ 22 M 
6261
9 
LEFT 
UNDESCENDED 
TESTIS 
A1 ORCHIDECTOMY GA 2 2 0 2 2 2 
22 REETA 25 F 
6588
9 
FIBROADENOMA A1 
WIDE LOCAL 
EXCISION 
GA 2 2 0 2 2 2 
88 
 
23 
SHANKAR 
KUMAR 
57 M 
6625
5 
VARICOSE VEIN A1 
TREDELENBERG 
PROCEDURE 
RA 2 2 0 2 2 2 
24 DIVYA 28 F 
6872
5 
FIBROADENOMA A1 
WIDE LOCAL 
EXCISION 
GA 2 2 0 2 2 2 
25 
NANDHIN
I 
25 F 
7134
5 
FIBROADENOMA A1 
WIDE LOCAL 
EXCISION 
GA 2 2 0 2 2 2 
26 DEVIKA 23 F 
7140
3 
FIBROADENOMA A1 
WIDE LOCAL 
EXCISION 
GA 2 2 0 2 2 2 
27 
KALIYAPP
AN 
37 M 
6827
4 
RAW AREA BACK A1 SSG GA 2 2 0 2 2 2 
28 KUMAR 57 M 
7069
6 
B/L VARICOSE 
VEIN 
A1 
TRENDELENBERG 
PROCEDURE 
SPI
NAL 
2 2 0 2 2 2 
29 
THIYAGA
RAJAN 
55 M 
7408
4 
PARAUMBILICAL 
HERNIA 
A1 MESH REPAIR 
SPI
NAL 
2 2 0 2 2 2 
30 SELVARAJ 48 M 
7393
3 
INGUINAL HERNIA A1 HERNIOPLASTY 
SPI
NAL 
2 2 0 2 2 2 
31 
PITCHAN
DI 
32 M 
7410
8 
INGUINAL HERNIA A1 HERNIOPLASTY 
SPI
NAL 
2 2 0 2 2 2 
32 PRABHU 26 M 
7404
3 
VARICOSE VEINS A1 
TRENDELENBERG 
PROCEDURE  
SPI
NAL 
2 2 0 2 2 2 
33 
SENBAGA
M 
35 F 
7361
5 
FIBROADENOMA A1 
WIDE LOCAL 
EXCISION 
GA 2 2 0 2 2 2 
34 
ESAKKIA
MMAL 
54 F 
7697
9 
LEFT CERVICAL 
LYMPHADENOPA
THY 
A1 EXCISION BIOPSY GA 2 2 0 2 2 2 
35 ARUL 42 M 
7716
5 
LEFT HYDROCELE A1 EVERSION OF SAC 
SPI
NAL 
1 
STAPH 
AURE
US 
3 1 1 2 
36 
UMAYA 
PARVATH
Y 
35 F 
7885
9 
FIBROADENOMA A1 
WIDE LOCAL 
EXCISION 
GA 2 2 0 2 2 2 
37 
VAJUMO
NISHA 
24 F 
7952
7 
FIBROADENOMA A1 
WIDE LOCAL 
EXCISION 
GA 2 2 0 2 2 2 
38 KENNADY 49 M 
7845
3 
LEFT HYDROCELE A1 EVERSION OF SAC 
SPI
NAL 
2 2 0 2 2 2 
39 KOSALA 30 F 
8243
6 
FIBROADENOMA A1 
WIDE LOCAL 
EXCISION 
GA 2 2 0 2 2 2 
40 SANDYA 24 F 
8233
3 
FIBROADENOMA A1 
WIDE LOCAL 
EXCISION 
GA 2 2 0 2 2 2 
41 
BAKRUDE
EN BABU 
57 M 
8191
8 
RIGHT 
HYDROCELE 
A1 EVERSION OF SAC 
SPI
NAL 
2 2 0 2 2 2 
42 SATHYA 45 F 
3186
47 
 PHYLLODES 
TUMOUR 
A1 
WIDE LOCAL 
EXCISION 
SPI
NAL 
2 2 0 2 2 2 
43 MALAR 45 F 
8259
7 
PARAUMBILICAL 
HERNIA 
A1 MESH PLASTY 
SPI
NAL 
2 2 0 2 2 2 
44 
BAKATHA
VATHSAL
AM 
57 M 
8499
6 
B/L VARICOSE 
VEINS 
A1 
LEFT 
TRENDELENBERG 
PROCEDURE 
SPI
NAL 
2 2 0 2 2 2 
45 PRABU 32 M 
8785
8 
LEFT 
HEMATOCELE 
A1 
LEFT 
ORCHIDECTOMY 
EVACUATION 
SPI
NAL 
2 2 0 2 2 2 
46 DEVI 26 F 
1006
75 
UMBILICAL 
HERNIA 
A1 
LAP/OPEN MESH 
PLASTY 
GA 2 2 0 2 2 2 
47 
RAJESWA
RI 
47 F 
3854
47 
GAINT CELL 
TUMOUR RIGHT 
INDEX FINGER 
A1 EXCISION BIOPSY RA 2 2 0 2 2 2 
48 BALAN 47 M 
9802
4 
PILONIDAL SINUS A1 LIMBERG FLAP 
SPI
NAL 
2 2 0 2 2 2 
89 
 
49 
MUNIYA
MMAL 
37 F 
1066
24 
B/L VARICOSE 
VEINS 
A1 
RIGHT 
TRENDELENBERG 
PROCEDURE 
SPI
NAL 
2 2 0 2 2 2 
50 JAYA 55 F 
1007
64 
PARAUMBILICAL 
HERNIA 
A1 MESH REPAIR 
SPI
NAL 
2 2 0 2 2 2 
1 ANBU 38 M 
1054
47 
LEFT VARICOSE 
VEINS 
A2 
LEFT 
TRENDELENBERG 
PROCEDURE 
SPI
NAL 
2 2 0 2 2 2 
2 SURESH 38 M 
1080
09 
LEFT HYDROCELE A2 EVERSION OF SAC 
SPI
NAL 
2 2 0 2 2 2 
3 
VINOTH 
KUMAR 
29 M 
1086
68 
UMBILICAL 
HERNIA 
A2 MESH REPAIR 
SPI
NAL 
2 2 0 2 2 2 
4 DEVI 43 F 
1087
93 
FIBROADENOMA A2 
WIDE LOCAL 
EXCISION 
GA 2 2 0 2 2 2 
5 LAKSHMI 30 F 
1106
19 
RECURRENT SCAR 
ENDOMETRIOMA 
A2 EXCISION BIOPSY 
SPI
NAL 
2 2 0 2 2 2 
6 
KRISHNA
N 
55 M 500 
LFT LL SOFT 
TISSUE SARCOMA 
A2 EXCISION BIOPSY 
SPI
NAL 
2 2 0 2 2 2 
7 
PACHIAP
PAN 
57 M 977 LEFT HYDROCELE A2 EVERSION OF SAC 
SPI
NAL 
2 2 0 2 2 2 
8 
NAGAVAL
LI 
37 F 
2880
0 
BREAST 
ANTIBIOMA 
A2 
WIDE LOCAL 
EXCISION 
GA 2 2 0 2 2 2 
9 SUBBULU 55 F 
2284
8 
RAW AREA RIGHT 
LEG 
A2 
SPLIT SKIN 
GRAFTING 
SPI
NAL 
2 2 0 2 2 2 
10 
MANIKKA
VEL 
35 M 
2977
1 
PARAUMBILICAL 
HERNIA 
A2 MESH PLASTY 
SPI
NAL 
2 2 0 2 2 2 
11 
SUGUMA
R 
35 M 
3262
8 
LEFT INGUINAL 
HERNIA 
A2 HERNIOPLASTY 
SPI
NAL 
2 2 0 2 2 2 
12 
PATTAM
MAL 
58 F 
2760
9 
RECTAL 
PROLAPSE 
A2 THIERSCH WIRING 
SPI
NAL 
2 2 0 2 2 2 
13 
BALARA
MAN 
52 M 
3820
6 
UMBLICAL SINUS A2 
RIGHT MESH 
REPAIR 
SPI
NAL 
2 2 0 2 2 2 
14 
YASUDOS
S 
58 M 
3836
8 
RIGHT 
HYDROCELE 
A2 EVERSION OF SAC 
SPI
NAL 
2 2 0 2 2 2 
15 DEVARAJ 29 M 
3891
1 
LEFT FOOT SCC A2 
LEFT 3RD TOE RAY 
AMPUTATION/SUP
ERFICIAL INGUINAL 
NODE EXICISION 
BIOPSY 
SPI
NAL 
2 2 0 2 2 2 
16 
DURAIVE
L 
38 M 
4370
7 
RIGHT 
HYDROCELE  
A2 EVERSION OF SAC 
SPI
NAL 
2 2 0 2 2 2 
17 
GIRIJA 
RANI 
30 F 
1588
14 
RIGHT PAROTID 
LN 
A2 ENUCLEATION 
SPI
NAL 
2 2 0 2 2 2 
18 
KRISHNA
SAMY 
33 M 
4878
4 
RIGHT 
HYDROCELE 
A2 EVERSION OF SAC 
SPI
NAL 
2 2 0 2 2 2 
19 RAJI 42 M 
4879
5 
LEFT HYDROCELE 
WITH 
SPERMATOCELE 
A2 EVERSION OF SAC 
SPI
NAL 
2 2 0 2 2 2 
20 RAMAN 25 M 
4926
0 
RIGHT 
HYDROCELE 
A2 HERNIOTOMY 
SPI
NAL 
2 2 0 2 2 2 
21 SATHYA 27 F 
5137
8 
PILONIDOL SINUS A2 Z-PLASTY 
SPI
NAL 
2 2 0 2 2 2 
22 ANITHA 31 F 
5449
6 
FIBROADENOMA A2 
WIDE LOCAL 
EXCISION 
GA 2 2 0 2 2 2 
90 
 
23 RAMAN 43 M 
4297
0 
SQUAMOUS CELL 
CARCINOMA 
RIGHT FOOT 
A2 
RIGHT FOREFOOT 
AMPUTATION  
SPI
NAL 
2 2 0 2 2 2 
24 SARASU 51 F 
5256
5 
LEFT LOWER LIMB 
VARICOSE VEINS 
A2 
TRENDELANBERG 
PROCEDURE 
SPI
NAL 
2 2 0 2 2 2 
25 
RAJENDR
AN 
46 M 
5178
8 
RIGHT INDIRECT 
INGUINAL HERNIA 
A2 
RIGHT 
HERNIOPLASTY 
SPI
NAL 
1 
STAPH 
AURE
US 
3 1 1 2 
26 
KRISHNA
MOORTH
Y 
38 M 
5261
9 
B/L HYDROCELE A2 EVERSION OF SAC SA 2 2 0 2 2 2 
27 
VEERAPP
AN 
51 M 
5594
7 
LEFT VARICOCELE 
WITH RIGHT 
ISCHEMIC 
ORCHITIS 
A2 
LEFT 
VARICOCELECTOM
Y 
SPI
NAL 
2 2 0 2 2 2 
28 
RAMASA
MY 
50 M 
6015
3 
LEFT HYDROCELE A2 EVERSION OF SAC 
SPI
NAL 
2 2 0 2 2 2 
29 SEKAR 44 M 
6107
9 
RIGHT INDIRECT 
INGUINAL HERNIA 
A2 
RIGHT 
HERNIOPLASTY 
SPI
NAL 
2 2 0 2 2 2 
30 
SASIKUM
AR 
37 M 
5842
7 
LEFT VARICOSE 
VEINS 
A2 
LEFT 
TRENDELENBERG 
PROCEDURE 
SPI
NAL 
2 2 0 2 2 2 
31 SWETHA 29 F 
6232
4 
PILONIDAL SINUS A2 
LIMBERG 
RHOMBOID FLAP 
SPI
NAL 
2 2 0 2 2 2 
32 VELMANI 52 M 
5895
7 
UMBILICAL 
HERNIA 
A2 MESH PLASTY 
SPI
NAL 
2 2 0 2 2 2 
33 
SRINIVAS
AN 
48 M 
6359
6 
RIGHT 
HYDROCELE 
A2 EVERSION OF SAC 
SPI
NAL 
2 2 0 2 2 2 
34 THASLI 26 F 
6360
1 
PARAUMBILICAL 
HERNIA 
A2 
LAP/OPEN MEDH 
PLASTY 
SPI
NAL 
2 2 0 2 2 2 
35 
SHYAMA
N 
45 M 
6461
4 
LEFT VARICOSE 
VEINS 
A2 
LEFT 
TRENDELENBERG 
PROCEDURE 
SPI
NAL 
2 2 0 2 2 2 
36 
SIVAGAM
I 
38 F 
4864
0 
RAWAREA LEFT 
FOOT 
A2 
SPLIT SKIN 
GRAFTING 
SPI
NAL 
2 2 0 2 2 2 
37 
SATHYAV
ANI 
38 F 
6919
3 
PHYLLOIDES 
TUMOUR 
A2 
WIDE LOCAL 
EXCISION 
GA 1 
STAPH 
AURE
US 
3 1 1 2 
38 
MANJUL
A 
38 F 
7916
9 
LEFT PAROTID 
LYMPHOMA 
A2 
EXCISION/INCISION 
BIOPSY 
SPI
NAL 
2 2 0 2 2 2 
39 SHANKAR 42 M 
7906
5 
LEFT VARICOSE 
VEIN 
A2 
LEFT 
TRENDELENBERG 
PROCEDURE 
SPI
NAL 
2 2 0 2 2 2 
40 
RAVIKUM
AR 
45 M 
7744
5 
B/L HYDROCELE A2 EVERSION OF SAC 
SPI
NAL 
2 2 0 2 2 2 
41 
CHANDR
AN 
37 M 
7377
0 
RAW AREA LEFT 
LOWER LIMB 
A2 SPILIT SKIN GRAFT 
SPI
NAL 
2 2 0 2 2 2 
42 
SIVALING
AM 
52 M 
9254
3 
B/L HYROCELE 
WITH BXO 
A2 
EVERSION OF SAC 
WITH 
CIRCUMCISION 
SPI
NAL 
2 2 0 2 2 2 
43 ANITHA 23 F 
9283
7 
FIBROADENOMA A2 
WIDE LOCAL 
EXCISION 
GA 2 2 0 2 2 2 
91 
 
44 PALANI 30 M 
1011
64 
LEFT POPLITEAL 
FOSSA SWELLING 
WITH 
PERIPHERAL 
NERVE SHEATH 
TUMOR 
A2 
EXCISION BIOPSY 
+/- NERVE 
GRAFTING 
(PLASTIC 
SURGERY)TEAM 
SPI
NAL 
2 2 0 2 2 2 
45 
RAJENDR
AN 
55 M 
1037
79 
RIGHT INDIRECT 
INGUINAL HERNIA 
A2 
RIGHT 
HERNIOPLASTY 
SPI
NAL 
2 2 0 2 2 2 
46 YUSAP 55 M 
1011
12 
RIGHT 
HYDROCELE 
A2 
RIGHT EVERSION 
OF SAC 
SA 2 2 0 2 2 2 
47 RAVI 45 M 
1021
3 
RIGHT INDIRECT 
INGUINAL 
A2 
RIGHT 
HERNIOPLASTY 
SPI
NAL 
2 2 0 2 2 2 
48 
RAJKUM
AR 
35 M 
1032
21 
RIGHT INDIRECT 
INGUINAL HERNIA 
A2 
RIGHT 
HERNIOPLASTY 
SPI
NAL 
2 2 0 2 2 2 
49 
GANESA
N 
42 M 
2664
3 
LEFT HYDROCELE A2 
LEFT EVERSION OF 
SAC 
SPI
NAL 
2 2 0 2 2 2 
50 
AMBUJA
M 
55 F 
2580
5 
LEFT VARICOSE 
VEIN 
A2 
LEFT 
TRENDELENBERG 
PROCEDURE 
SPI
NAL 
2 2 0 2 2 2 
 
